Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Altek Interim / Quarterly Report 2024

Nov 14, 2024

52290_rns_2024-11-14_960cbd5b-8ce4-45c2-8ac0-3828cb04b7f2.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

ALTEK CORPORATION AND SUBSIDIARIES

CONSOLIDATED FINANCIAL STATEMENTS AND

INDEPENDENT AUDITORS’ REVIEW REPORT SIX MONTHS ENDED JUNE 30, 2024 AND 2023 (Stock Code3059)

~1~

INDEPENDENT AUDITORS’ REVIEW REPORT TRANSLATED FROM CHINESE

PWCR24000073

To ALTEK CORPORATION

Introduction

We have reviewed the accompanying consolidated balance sheets of Altek Corporation and subsidiaries as at June 30, 2024 and 2023, and the related consolidated statements of comprehensive income for the three-month and six-month periods then ended, as well as the consolidated statements of changes in equity and of cash flows for the six-month periods then ended, and notes to the consolidated financial statements, including a summary of material accounting policies. Management is responsible for the preparation and fair presentation of these consolidated financial statements in accordance with Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34 “Interim Financial Reporting” that came into effect as endorsed by Financial Supervisory Commission. Our responsibility is to express a conclusion on these consolidated financial statements based on our reviews.

Scope of Review

Except as explained in the following paragraph, we conducted our reviews in accordance with the Standards on Review Engagement 2410, “Review of Financial Information Performed by the Independent Auditor of the Entity” of the Republic of China. A review of consolidated financial statements consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Basis for qualified conclusion

As explained in Note 4(3), the financial statements of non-significant consolidated subsidiaries and the information disclosed in Note 13 were based solely on the reports prepared by those subsidiaries which were not reviewed by independent auditors. Those statements reflect total assets of NT $4,651,145 thousand and NT $2,285,025 thousand, constituting 30% and 14% of the consolidated total assets, and total liabilities of NT $966,440 thousand and NT $1,084,650 thousand, constituting

~2~

17% and 15% of the consolidated total liabilities as at June 30, 2024 and 2023, respectively, and total comprehensive (loss) income of NT $34,055 thousand, NT($86,457) thousand, NT $74,563 thousand and NT($123,401) thousand, constituting 17%, (288%), 12% and (122%) of the consolidated total comprehensive income for the three-month and six-month periods then ended, respectively.

Qualified Conclusion

Except for the adjustments to the consolidated financial statements, if any, as might have been determined to be necessary had the financial statements of non-significant consolidated subsidiaries been reviewed by independent auditors, as described in the please italicize section above, based on our reviews, nothing has come to our attention that causes us to believe that the accompanying consolidated financial statements do not present fairly, in all material respects, the consolidated financial position of the Group as at June 30, 2024 and 2023, and its consolidated financial performance for the three-month and six-month periods then ended and its consolidated cash flows for the six-month periods then ended in accordance with Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34, “Interim Financial Reporting” that came into effect as endorsed by the Financial Supervisory Commission.

Chiang, Tsai-Yen Hsieh, Chih-Cheng For and on behalf of PricewaterhouseCoopers, Taiwan August 9, 2024


The accompanying consolidated financial statements are not intended to present the financial position and results of operations and cash flows in accordance with accounting principles generally accepted in countries and jurisdictions other than the Republic of China. The standards, procedures and practices in the Republic of China governing the audit of such financial statements may differ from those generally accepted in countries and jurisdictions other than the Republic of China. Accordingly, the accompanying consolidated financial statements and independent auditors’ report are not intended for use by those who are not informed about the accounting principles or auditing standards generally accepted in the Republic of China, and their applications in practice.

As the financial statements are the responsibility of the management, PricewaterhouseCoopers, Taiwan cannot accept any liability for the use of, or reliance on, the English translation or for any errors or misunderstandings that may derive from the translation.

~3~

ALTEK CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS JUNE 30, 2024, DECEMBER 31, 2023 AND JUNE 30, 2023

(Expressed in thousands of New Taiwan dollars)

Assets Notes June 30,2024
AMOUNT
%
$ 3,772,714
25
2,417,635
16
36,001
-
1,104,031
7
109,452
1
2,512
-
1,511,111
10
219,536
1
6,241
-
9,179,233
60
125,403
1
38,361
-
1,512,887
10
2,681,897
18
135,868
1
1,343,102
9
181,933
1
78,466
-
34,345
-
6,132,262
40
$ 15,311,495
100
December31,2023
AMOUNT
%
$ 5,798,794
38
390,169
2
28,796
-
1,741,007
11
68,885
-
1,298
-
1,762,109
11
342,470
2
4,072
-
10,137,600
64
124,007
1
38,461
-
1,083,803
7
2,614,119
17
144,286
1
1,326,463
8
164,789
1
173,077
1
35,953
-
5,704,958
36
$ 15,842,558
100
June 30,2023 June 30,2023
AMOUNT
$ 3,772,714
2,417,635
36,001
1,104,031
109,452
2,512
1,511,111
219,536
6,241
9,179,233
125,403
38,361
1,512,887
2,681,897
135,868
1,343,102
181,933
78,466
34,345
6,132,262
$ 15,311,495
AMOUNT
$ 5,798,794
390,169
28,796
1,741,007
68,885
1,298
1,762,109
342,470
4,072
10,137,600
124,007
38,461
1,083,803
2,614,119
144,286
1,326,463
164,789
173,077
35,953
5,704,958
$ 15,842,558
AMOUNT
$ 6,062,081
387,860
46,726
1,624,152
58,081
6,397
1,808,796
490,246
4,841
10,489,180
107,600
71,545
948,103
2,615,156
155,069
1,335,498
272,365
177,927
39,158
5,722,421
$ 16,211,601
%
Current assets
1100
Cash and cash equivalents
1136
Current financial assets at
amortised cost
1150
Notes receivable, net
1170
Accounts receivable, net
1200
Other receivables
1220
Current income tax assets
130X
Inventories
1410
Prepayments
1470
Other current assets
11XX
Current assets
Non-current assets
1510
Non-current financial assets at
fair value through profit or loss
1517
Non-current financial assets at
fair value through other
comprehensive income
1535
Non-current financial assets at
amortised cost
1600
Property, plant and equipment
1755
Right-of-use assets
1760
Investment property
1780
Intangible assets
1840
Deferred income tax assets
1900
Other non-current assets
15XX
Non-current assets
1XXX
Total assets
6(1)
6(4)
6(5)
6(5)
6(6)
6(2)
6(3)
6(4)
6(7) and 8
6(8)
6(9) and 8
6(10)
38
3
-
10
-
-
11
3
-
65
1
-
6
16
1
8
2
1
-
35
100

(Continued)

~4~

ALTEK CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS JUNE 30, 2024, DECEMBER 31, 2023 AND JUNE 30, 2023

(Expressed in thousands of New Taiwan dollars)

June 30,2024 December31,2023 December31,2023 June 30,2023
Liabilities and Equity Notes AMOUNT % AMOUNT % AMOUNT %
Current liabilities
2100 Short-term borrowings 6(11) $ 1,617,044 11 $ 2,234,704 14 $ 2,244,191 14
2110 Short-term notes and bills 6(12)
payable - - - - 99,934 1
2130 Current contract liabilities 6(22) 191,253 1 351,051 2 455,805 3
2170 Accounts payable 1,044,253 7 1,240,588 8 1,470,145 9
2200 Other payables 6(14) 999,578 6 917,502 6 1,015,253 6
2230 Current income tax liabilities 116,644 1 150,780 1 130,677 1
2250 Provisions - current 6(17) 74,099 - 67,256 - 58,885 -
2280 Current lease liabilities 16,952 - 18,523 - 17,471 -
2320 Long-term borrowings, current 6(13) and 8
portion 900,000 6 - - - -
2399 Other current liabilities, others 82,764 1 91,926 1 180,698 1
21XX Current liabilities 5,042,587 33 5,072,330 32 5,673,059 35
Non-current liabilities
2540 Long-term borrowings 6(13) and 8 - - 900,000 6 900,000 5
2550 Provisions - non-current 6(17) 124,032 1 130,998 1 135,009 1
2570 Deferred income tax liabilities 463,564 3 463,086 3 452,732 3
2580 Non-current lease liabilities 106,860 1 113,652 1 122,217 1
2600 Other non-current liabilities 40,787 - 39,726 - 40,257 -
25XX Non-current liabilities 735,243 5 1,647,462 11 1,650,215 10
2XXX Total liabilities 5,777,830 38 6,719,792 43 7,323,274 45
Equity attributable to owners of
the parent
Share capital 6(18)
3110 Common stock 2,788,000 18 2,788,000 18 2,788,000 17
Capital surplus 6(19)
3200 Capital surplus 2,053,174 13 2,046,394 13 2,046,394 13
Retained earnings 6(20)
3310 Legal reserve 1,512,604 10 1,484,678 9 1,484,678 9
3320 Special reserve 624,316 4 515,412 3 515,412 3
3350 Unappropriated retained
earnings 2,408,173 16 2,584,914 16 2,395,965 15
Other equity interest 6(21)
3400 Other equity interest ( 228,834)( 2)( 624,316)( 4)( 580,305)( 4)
3500 Treasury stocks 6(18) ( 38,101) - ( 38,101) - ( 38,101) -
31XX Equity attributable to
owners of the parent 9,119,332 59 8,756,981 55 8,612,043 53
36XX Non-controlling interest 414,333 3 365,785 2 276,284 2
3XXX Total equity 9,533,665 62 9,122,766 57 8,888,327 55
3X2X Total liabilities and equity $ 15,311,495 100 $ 15,842,558 100 $ 16,211,601 100

The accompanying notes are an integral part of these consolidated financial statements.

~5~

ALTEK CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

THREE-MONTH AND SIX-MONTH PERIODS ENDED JUNE 30, 2024 AND 2023

(Expressed in thousands of New Taiwan dollars, except earnings per share amount)

Threemonths Threemonths Threemonths ended June 30 ended June 30 Six months ended June 30 Six months ended June 30 Six months ended June 30 Six months ended June 30 Six months ended June 30
2024 2023 2024 2023
Items Notes AMOUNT % AMOUNT % AMOUNT % AMOUNT %
4000 Operating revenue 6(22) $ 1,704,446 100 $ 2,208,835 100 $ 3,304,288 100 $ 4,462,412 100
5000 Operating costs 6(6)(27)(28) ( 1,159,865) ( 68) ( 1,647,468) ( 75) ( 2,274,168) ( 69) ( 3,396,703) ( 76)
5900 Net operating margin 544,581 32 561,367 25 1,030,120 31 1,065,709 24
Operating expenses 6(27)(28)
6100 Selling and marketing expenses ( 40,332) ( 2) ( 32,486) ( 1) ( 67,747) ( 2) ( 60,625) ( 1)
6200 General and administrative
expenses ( 145,237) ( 9) ( 129,145) ( 6) ( 265,477) ( 8) ( 254,030) ( 6)
6300 Research and development
expenses ( 263,207) ( 15) ( 305,850) ( 14) ( 522,000) ( 16) ( 594,688) ( 13)
6450 Expected credit gain (loss) 12(2) ( 150) - ( 23) - 1,104 - ( 238) -
6000 Total operating expenses ( 448,926) ( 26) ( 467,504) ( 21) ( 854,120) ( 26) ( 909,581) ( 20)
6900 Operating profit 95,655 6 93,863 4 176,000 5 156,128 4
Non-operating income and expenses
7100 Interest income 6(23) 56,312 3 54,858 3 104,447 3 91,553 2
7010 Other income 6(24) 24,020 1 25,652 1 49,820 2 48,101 1
7020 Other gains and losses 6(25) ( 6,758) - ( 8,691) - 1,755 - ( 9,251) -
7050 Finance costs 6(26) ( 13,199) ( 1) ( 16,679) ( 1) ( 28,614) ( 1) ( 32,965) ( 1)
7000 Total non-operating income and
expenses 60,375 3 55,140 3 127,408 4 97,438 2
7900 Profit before income tax 156,030 9 149,003 7 303,408 9 253,566 6
7950 Income tax expense 6(29) ( 46,608) ( 3) ( 52,795) ( 3) ( 93,255) ( 3) ( 83,623) ( 2)
8200 Profit for the period $ 109,422 6 $ 96,208 4 $ 210,153 6 $ 169,943 4
Other comprehensive income (loss)
Components of other comprehensive
income (loss) that will not be
reclassified to profit or loss
8316 Unrealised gain (loss) from 6(3)
financial assets measured at fair
value through other comprehensive
loss ($ 1,102) - $ 1,974 - ($ 4,400) - $ 1,658 -
Components of other comprehensive
income (loss) that may be
reclassified to profit or loss
8361 Currency translation differences of
foreign operations 111,089 7 ( 84,205) ( 4) 506,262 15 ( 87,126) ( 2)
8399 Income tax relating to the 6(29)
components of other
comprehensive income (loss) that
may be reclassified to profit or loss ( 21,763) ( 1) 16,046 1 ( 99,970) ( 2) 16,638 -
8360 Components of other
comprehensive income (loss)
that may be reclassified to profit
or loss 89,326 6 ( 68,159) ( 3) 406,292 13 ( 70,488) ( 2)
8300 Total other comprehensive income
(loss) for the period $ 88,224 6 ($ 66,185) ( 3) $ 401,892 13 ($ 68,830) ( 2)
8500 Total comprehensive income for the
period $ 197,646 12 $ 30,023 1 $ 612,045 19 $ 101,113 2
Profit, attributable to:
8610 Owners of the parent $ 77,380 4 $ 91,969 4 $ 153,786 4 $ 158,325 4
8620 Non-controlling interest 32,042 2 4,239 - 56,367 2 11,618 -
Profit for the period $ 109,422 6 $ 96,208 4 $ 210,153 6 $ 169,943 4
Comprehensive income attributable to:
8710 Owners of the parent $ 163,334 10 $ 29,759 1 $ 549,268 17 $ 93,431 2
8720 Non-controlling interest 34,312 2 264 - 62,777 2 7,682 -
Total comprehensive income for
the period $ 197,646 12 $ 30,023 1 $ 612,045 19 $ 101,113 2
9750 Basic earnings per share (in 6(30)
dollars) $ 0.28 $ 0.33 $ 0.56 $ 0.57
9850 Diluted earnings per share (in 6(30)
dollars) $ 0.28 $ 0.33 $ 0.55 $ 0.57

The accompanying notes are an integral part of these consolidated financial statements.

~6~

ALTEK CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY SIX-MONTH PERIODS ENDED JUNE 30, 2024 AND 2023

(Expressed in thousands of New Taiwan dollars)

Six-month period ended June 30, 2023
Balance at January 1, 2023
Profit for the period
Other comprehensive income (loss) for the
period
Total comprehensive income (loss)
Appropriation of 2022 earnings
Legal reserve
Special reserve
Cash dividends
Share-based payment transactions
Retirement of employee restricted shares
Difference between consideration and carrying
amount of subsidiaries acquired
Non-controlling interest
Balance at June 30, 2023
Six-month period ended June 30, 2024
Balance at January 1, 2024
Profit for the period
Other comprehensive income (loss) for the
period
Total comprehensive income (loss)
Appropriation of 2023 earnings
Legal reserve
Special reserve
Cash dividends
Share-based payment transactions
Changes in ownership interests in subsidiaries
Non-controlling interest
Balance at June 30, 2024
Notes Equity attribu Equity attribu tableto owners of th e parent e parent Non-controlling
interest
Totalequity
Commonstock Capitalsurplus Retained earnings Otherequityinterest Treasury
stocks
Total
Legal reserve Special reserve Unappropriated
retained earnings
Currency
translation
differences of
foreignoperations
Other
6(21)
6(20)
6(16)(21)
6(16)(18)(19)(21)
6(31)
6(21)
6(20)
6(16)
6(19)
$2,788,180
-
-
-
-
-
-
-
(
180 )
-
-
$2,788,000
$2,788,000
-
-
-
-
-
-
-
-
-
$2,788,000
$2,046,625
-
-
-
-
-
-
-
(
231 )
-
-
$2,046,394
$2,046,394
-
-
-
-
-
-
-
6,780
-
$2,053,174
$1,441,002
-
-
-
43,676
-
-
-
-
-
-
$1,484,678
$1,484,678
-
-
-
27,926
-
-
-
-
-
$1,512,604
$774,832
-
-
-
-
(
259,420 )
-
-
-
-
-
$515,412
$515,412
-
-
-
-
108,904
-
-
-
-
$624,316
$ 2,366,630
158,325
-
158,325
(
43,676 )
259,420
(
276,728 )
-
-
(
68,006 )
-
$ 2,395,965
$ 2,584,914
153,786
-
153,786
(
27,926 )
(
108,904 )
(
193,697 )
-
-
-
$ 2,408,173
($ 367,270 )
-
(
66,552 )
(
66,552 )
-
-
-
-
-
-
-
($ 433,822 )
($ 445,272 )
-
399,882
399,882
-
-
-
-
-
-
($ 45,390 )
($148,837 )
-
1,658
1,658
-
-
-
285
411
-
-
($146,483 )
($179,044 )
-
(
4,400 )
(
4,400 )
-
-
-
-
-
-
($183,444 )
($38,101 )
-
-
-
-
-
-
-
-
-
-
($38,101 )
($38,101 )
-
-
-
-
-
-
-
-
-
($38,101 )
$8,863,061
158,325
(
64,894 )
93,431
-
-
(
276,728 )
285
-
(
68,006 )
-
$8,612,043
$8,756,981
153,786
395,482
549,268
-
-
(
193,697 )
-
6,780
-
$9,119,332
$333,867
11,618
(
3,936 )
7,682
-
-
-
-
-
(
5,674 )
(
59,591 )
$276,284
$365,785
56,367
6,410
62,777
-
-
-
15,102
(
6,780 )
(
22,551 )
$414,333
$9,196,928
169,943
(
68,830 )
101,113
-
-
(
276,728 )
285
-
(
73,680 )
(
59,591 )
$8,888,327
$9,122,766
210,153
401,892
612,045
-
-
(
193,697 )
15,102
-
(
22,551 )
$9,533,665

The accompanying notes are an integral part of these consolidated financial statements.

~7~

ALTEK CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS

SIX-MONTH PERIODS ENDED JUNE 30, 2024 AND 2023

(Expressed in thousands of New Taiwan dollars)

CASH FLOWS FROM OPERATING ACTIVITIES
Profit before tax
Adjustments
Adjustments to reconcile (profit) loss
Depreciation
Amortisation
Expected credit (gain) loss
Net loss on financial assets at fair value through
profit or loss
Interest expense
Interest income
Share-based payment compensation cost
Gain on disposal of property, plant and
equipment
Changes in operating assets and liabilities
Changes in operating assets
Current contract assets
Notes receivable
Accounts receivable
Other receivables
Inventories
Prepayments
Other current assets
Changes in operating liabilities
Current contract liabilities
Accounts payable
Other payables
Provisions
Other current liabilities
Other non-current liabilities
Cash inflow generated from operations
Interest received
Interest paid
Income tax paid
Net cash flows from operating activities
Six-month periods ended June 30
Notes
2024
2023
$ 303,408
$ 253,566
6(7)(8)(9)(27)
83,551
102,288
6(10)(27)
20,095
78,602
12(2)
(
1,104 )
238
6(2)(25)
549
6,860
6(26)
28,614
32,965
6(23)
(
104,447 ) (
91,553 )
6(16)
15,102
285
6(25)
(
17 ) (
11 )
-
21,033
(
5,674 ) (
45,641 )
657,582
552,047
(
10,700 ) (
8,324 )
334,719
573,550
98,799
(
109,742 )
(
1,943 )
1,001
(
161,597 )
16,920
(
248,547 ) (
135,143 )
(
143,215 ) (
84,528 )
(
307 )
7,469
(
10,792 )
17,674
(
488) (
395)
853,588
1,189,161
78,336
89,010
(
26,874 ) (
28,009 )
(
134,865) (
43,190)
770,185
1,206,972

(Continued)

~8~

ALTEK CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS

SIX-MONTH PERIODS ENDED JUNE 30, 2024 AND 2023

(Expressed in thousands of New Taiwan dollars)

CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of financial assets at fair value through
profit or loss
Proceeds from disposals of financial asset at fair
value through profit or loss
Acquisition of financial assets at amortised cost
Proceeds from repayments of financial assets at
amortised cost
Proceeds from capital reduction of financial assets
at fair value through other comprehensive income
Acquisition of property, plant and equipment
Proceeds from disposal of property, plant and
equipment
Acquisition of intangible assets
Decrease (increase) in deposits paid
Increase in deposits paid
Net cash flows used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from short-term borrowings
Repayment of short-term borrowings
Proceeds from issuance of short-term notes and bills
payable
Repayment of short-term notes and bills payable
Proceeds from long-term borrowings
Repayment of long-term borrowings
Increase in guarantee deposits received
Decrease in guarantee deposits received
Repayment of principal portion of lease liabilities
Changes in non-controlling interest
Net cash flows used in financing activities
Effect of exchange rate
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Six-month periods ended June 30
Notes
2024
2023
$ -
($ 30,325 )
-
281
(
2,752,670 ) (
1,368,040 )
409,813
970,867
1,607
2,323
6(32)
(
41,602 ) (
44,335 )
17
11
6(32)
(
3,829 ) (
3,160 )
-
(
5,856 )
1,961
-
(
2,384,703) (
478,234)
6(33)
3,458,391
8,644,261
6(33)
(
4,081,000 ) (
8,611,000 )
6(33)
-
1,097,985
6(33)
-
(
1,400,000 )
6(33)
-
900,000
-
(
500,000 )
6(33)
45
-
6(33)
-
(
9 )
6(33)
(
11,029 ) (
10,051 )
(
22,551) (
133,271)
(
656,144) (
12,085)
244,582
(
14,045)
(
2,026,080 )
702,608
6(1)
5,798,794
5,359,473
6(1)
$ 3,772,714
$ 6,062,081

The accompanying notes are an integral part of these consolidated financial statements.

~9~

ALTEK CORPORATION AND SUBSIDIARIES

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

SIX-MONTH PERIODS ENDED JUNE 30, 2024 AND 2023

(Expressed in thousands of New Taiwan dollars, except as otherwise indicated)

1. HISTORY AND ORGANIZATION

Altek Corporation (the “Company”) was incorporated as a company limited by shares under the provisions of the Company Act of the Republic of China (R.O.C.). The Company and its subsidiaries (collectively referred herein as the “Group”) are primarily engaged in the development, manufacturing and sale of automobile cameras, medical and digital image technology application products, and related export and import trade.

The Company was listed in the Taiwan Stock Exchange on December 24, 2002, as approved by the TaiTz (91) Letter No. 024976 of the former Securities and Futures Commission, Ministry of Finance, R.O.C., dated September 27, 2002.

  1. THE DATE OF AUTHORISATION FOR ISSUANCE OF THE CONSOLIDATED FINANCIAL

STATEMENTS AND PROCEDURES FOR AUTHORISATION

These consolidated financial statements were reported to the Board of Directors and issued on August 9, 2024.

3. APPLICATION OF NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS

  • (1) Effect of the adoption of new issuances of or amendments to International Financial Reporting Standards (“IFRS”) Accounting Standards that came into effect as endorsed by the Financial Supervisory Commission (“FSC”)

New standards, interpretations and amendments endorsed by FSC and become effective from 2024 are as follows:

are as follows:
New Standards,Interpretations and Amendments Effective date by
International Accounting
Standards Board
("IASB")
Amendments to IFRS 16, ‘Lease liability in a sale and leaseback’
Amendments to IAS 1, ‘Classification of liabilities as current or
non-current’
Amendments to IAS 1, ‘Non-current liabilities with covenants’
Amendments to IAS 7 and IFRS 7, ‘Supplier finance arrangements’
January 1, 2024
January 1, 2024
January 1, 2024
January 1, 2024

The above standards and interpretations have no significant impact to the Group’s financial condition and financial performance based on the Group’s assessment.

~10~

(2) Effect of new issuances of or amendments to IFRS Accounting Standards as endorsed by the FSC

but not yet adopted by the Group

New standards, interpretations and amendments endorsed by the FSC effective from 2025 are as follows:.

follows:.
Effective date by
New Standards,InterpretationsandAmendments IASB
Amendments to IAS 21, ‘Lack of exchangeability’ January 1, 2025
The above standards and interpretations have no significant impact to the Group’s financial condition
and financial performance based on the Group’s assessment.

(3) IFRS Accounting Standards issued by IASB but not yet endorsed by the FSC

New standards, interpretations and amendments issued by IASB but not yet included in the IFRS Accounting Standards as endorsed by the FSC are as follows:

New Standards,InterpretationsandAmendments Effective date by
IASB
Amendments to IFRS 9 and IFRS 7, ‘Amendments to the classification
and measurement of financial Instruments’
Amendments to IFRS 10 and IAS 28, ‘Sale or contribution of assets
between an investor and its associate or joint venture’
IFRS 17, ‘Insurance contracts’
Amendments to IFRS 17, ‘Insurance contracts’
Amendment to IFRS 17, ‘Initial application of IFRS 17 and IFRS 9 –
comparative information’
IFRS 18, ‘Presentation and disclosure in financial statements’
IFRS 19, ‘Subsidiaries without public accountability: disclosures’
Annual Improvements to IFRS Accounting Standards—Volume 11
January 1, 2026
To be determined by
IASB
January 1, 2023
January 1, 2023
January 1, 2023
January 1, 2027
January 1, 2027
January 1, 2026

Except for the following, the above standards and interpretations have no significant impact to the Group’s financial condition and financial performance based on the Group’s assessment.

  • A. Amendments to IFRS 9 and IFRS 7, ‘Amendments to the classification and measurement of financial instruments’

The IASB issued the amendments to:

Update the disclosures for equity instruments designated at fair value through other comprehensive income (FVOCI). The entity shall disclose the fair value of each class of investment and is no longer required to disclose the fair value of each investment. In addition, the amendments require the entity to disclose the fair value gain or loss presented in other comprehensive income during the period, showing separately the fair value gain or loss related to investments derecognised during the reporting period and the fair value gain or loss related to investments held at the end of the reporting period; and any transfers of the cumulative gain or loss within equity related to the investments derecognised during that reporting period.

~11~

  • B. IFRS 18, ‘Disclosure and presentation of financial statements’

  • IFRS 18, ‘Disclosure and presentation of financial statements’ replaces IAS 1 and updates the structure of the consolidated comprehensive income statement, adds disclosure of management performance measures, and strengthens the summary and segmentation principles applied to the major financial statements and notes.

4. SUMMARY OF MATERIAL ACCOUNTING POLICIES

The principal accounting policies adopted are consistent with Note 4 in the consolidated financial statements for the year ended December 31, 2023, except for the compliance statement, basis of preparation, basis of consolidation and additional policies as set out below. These policies have been consistently applied to all the periods presented, unless otherwise stated.

(1) Compliance statement

  • A. The consolidated financial statements of the Group have been prepared in accordance with the Rules Governing the Preparation of Financial Statements by Securities Issuers and IAS 34, ‘Interim financial reporting’ that came into effect as endorsed by the FSC.

  • B. The consolidated financial statements should be read together with the 2023 consolidated financial statements.

(2) Basis of preparation

  • A. Except for the following items, the consolidated financial statements have been prepared under the historical cost convention:

  • (a) Financial assets (including derivative instruments) at fair value through profit or loss.

  • (b) Financial assets at fair value through other comprehensive income.

  • (c) Defined benefit liabilities recognised based on the net amount of pension fund assets less present value of defined benefit obligation.

  • B. The preparation of financial statements in conformity with International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations, and SIC Interpretations that came into effect as endorsed by the FSC (collectively referred herein as the “IFRSs”) requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the Group’s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements are disclosed in Note 5.

(3) Basis of consolidation

  • A. Basis for preparation of consolidated financial statements:

  • Basis for preparation of consolidated financial statements is consistent with the 2023 consolidated financial statements.

  • B. Subsidiaries included in the consolidated financial statements:

~12~

Name of Investor Name ofSubsidiaries Main BusinessActivities Ownership (%) Note
June 30,2024
100
100
100
100
69.87
100
100
100
100
-
100
100
100
100
100
100
75
100
100
100
100
100
100
100
100
er 1, 2023.
of an significant subsidiary fr
December31,2023
100
100
100
100
75.11
100
100
100
100
100
100
100
100
100
100
100
75
100
100
100
100
100
100
100
100
om 2024, the financial state
June 30,2023
Altek Corporation
Altek International Investment Co., Ltd.
Investments
"
Altek Japan Corporation
Buying and selling of electronic components
"
Altek International Holding (BVI) Co., Ltd.
Investments
"
Altek Investment Corporation
Investments
"
Altek Medical Pte. Ltd.
Research and development, sales of medical electronic equipment and investment
Altek International Investment Co., Ltd.
Altek Lab Inc.
Collection of American digital imaging technology information and design services
"
Altek Semiconductor (Cayman) Co., Ltd.
Investments
"
Altek Optical Technology (Cayman) Co., Ltd.
Investments
"
Altek International Trading Co., Ltd.
Intercompany transactions
Altek Investment Corporation
Ptek Corporation
Product development and design
Note 1
Altek (Kunshan) Co., Ltd.
Manufacture and sales of digital still camera and its accessories
Note 1
Jia Jing Business Management (Kunshan) Co.,
Ltd.
Business management and non-residential real estate leasing
Note 1
Hong Jing Business Management (Kunshan)
Co., Ltd.
Business management, housing leasing and property management
Note 1
Altek EMS (Kunshan) Co., Ltd.
Production /sales of electronic product components
Note 1
Altek Precision (Kunshan) Co., Ltd.
Manufacture and sales of digital camera parts
Note 1
Altek Trading (Shanghai) Limited
Wholesale, import and export of related electronic and their associated accessories
Altek Optical Technology (Cayman) Co., Ltd.
Altek Optical Technology (Kunshan) Co., Ltd.
Manufacture and sales of photo electron device, optical instrument, camera and
equipment
Altek Semiconductor (Cayman) Co., Ltd.
Altek Semiconductor Corporation
Research design and sales of ASIC
Altek Trading (Shanghai) Limited
Altek Semiconductor (Shanghai) Co., Ltd.
Research design and sales of imaging technologies,
electronic software and hardware
Altek Medical Pte. Ltd.
Altek Biotechnology Corporation
Research and development, manufacture and sales of medical electronic equipments
"
Altek Medical (HongKong) Limited
Investments
"
Altek Biotechnology Pte. Ltd.
Research and development and sales of medical electronic equipments
"
Altek Medical Sdn. Bhd.
Manufacture and sales of medical electronic equipments
Altek Medical (HongKong) Limited
Altek Medical (Shanghai) Limited
Sales of medical electronic equipments
Altek Medical (Shanghai) Limited
Altek Medical (Kunshan) Limited
Manufacture and sales of medical electronic equipments
Note 1: Invested by Leading Tech. Co., Ltd., Toptek Investment Cayman Co., Ltd., Altek Trading (Cayman) Co., Ltd., which are wholly owned by Altek International Investment Co., Ltd.
Note 2: Ptek Corporation was dissolved and liquidated on October 24, 2022 by the resolution of its board of directors, and dissolved with the approval of the competent authority on Novemb
Note 3: Altek Medical Holding (Cayman) Co., Ltd. relocated to Singapore on April 13, 2023, and changed its name to Altek Medical Pte. Ltd.
Note 4: The Group's ownership decreased due to the issuance of restricted shares to employee by the subsidiary.
Note 5: It was established by Altek (Kunshan) Co., Ltd. by business division on December 19, 2023.
Note 6:As the subsidiaries did not meet the definition of significant subsidiaries, the financial statements as of June 30, 2024 and 2023 were not reviewed by independent auditors.
Note 7:As the subsidiaries did not meet the definition of significant subsidiaries, the financial statements as of June 30, 2023 were not reviewed by independent auditors.
Note 8:As the subsidiaries did not meet the definition of significant subsidiaries, the financial statements as of June 30, 2024 were not reviewed by independent auditors.
Note 9: In 2023, it meets the definition of an significant subsidiary, the financial statements as of June 30, 2023 were reviewed by independent auditors. Since it does not meet the definition
were not been reviewed by independent auditors.
100
100
100
100
77.70
100
100
100
100
100
100
-
-
100
100
100
75
100
100
100
100
100
100
100
100
ments as of June 30, 2024
-
Note 6
Note 9
Note 6
Note 3
Note 4
Note 6
Note 6
Note 6
Note 6
Note 2
Note 7
-
Note 5
Note 8
Note 5
Note 8
Note 6
Note 6
Note 6
Note 6
Note 6
Note 6
Note 3
Note 3
Note 6
Note 3
Note 6
Note 3
Note 6
Note 6
Note 6

~13~

  • C. Subsidiaries not included in the consolidated financial statements: None.

  • D. Adjustments for subsidiaries with different balance sheet dates: None.

  • E. Significant restrictions: None.

  • F. Subsidiaries that have non-controlling interests that are material to the Group: None.

(4) Employee benefits

Pension-Defined benefit plans

Pension cost for the interim period is calculated on a year-to-date basis by using the pension cost rate derived from the actuarial valuation at the end of the prior financial year, adjusted for significant market fluctuations since that time and for significant curtailments, settlements, or other significant one-off events. And, the related information is disclosed accordingly.

(5) Income tax

The interim period income tax expense is recognised based on the estimated average annual effective income tax rate expected for the full financial year applied to the pretax income of the interim period, and the related information is disclosed accordingly.

5. CRITICAL ACCOUNTING JUDGEMENTS, ESTIMATES AND KEY SOURCES OF ASSUMPTION

UNCERTAINTY

There have been no significant changes during the period. Please refer to Note 5 in the consolidated financial statements for the year ended December 31, 2023.

6. DETAILS OF SIGNIFICANT ACCOUNTS

(1) Cash and cash equivalents

Cash on hand
Checking and demand accounts
Time deposits
Total
June 30,2024
December31,2023
1,443
$ 1,283
$ 1,306,636
1,531,317
2,464,635
4,266,194
3,772,714
$ 5,798,794
$
June 30,2023
1,896
$ 2,058,726
4,001,459
6,062,081
$
  • A. The Group transacts with a variety of financial institutions all with high credit quality to disperse credit risk, so it expects that the probability of counterparty default is remote.

  • B. The Group has no cash and cash equivalents pledged to others.

(2) Financial assets at fair value through profit or loss

Asset Items
Non-current items:
Financial assets mandatorily
measured at fair value through
profit or loss
Unlisted stocks
Hybrid instruments
Valuation adjustment
Total
June 30,2024
December31,2023
10,312
$ 10,312
$ 32,450
30,705
82,641
82,990
125,403
$ 124,007
$
June 30,2023
10,312
$ 31,140
66,148
107,600
$

~14~

  • A. Amounts recognised in profit or loss in relation to financial assets at fair value through profit or loss are listed below:
loss are listed below:
Three-month Three-month
period ended June 30, 2024 period ended June 30,2023
Equity instruments ($ 519)
($ 12,597)
Derivatives - ( 94)
Total ($ 519) ($ 12,691)
Six-month Six-month
period ended June 30, 2024 period ended June 30,2023
Equity instruments ($ 549)
($ 7,141)
Derivatives - 281
Total ($ 549) ($ 6,860)
  • B. The Group has no financial assets measured at fair value through profit and loss as at June 30, 2024, December 31, 2023, and June 30, 2023, pledged to others.

(3) Financial assets at fair value through other comprehensive income

Items
Non-current items:
Equity instruments
Unlisted stocks
Valuation adjustment

Total
June 30,2024
December31,2023
221,806
$ 217,506
$ 183,445)
(
179,045)
(
(
38,361
$ 38,461
$
June 30,2023
218,029
$ 146,484)

71,545
$
  • A. The Group has elected to classify equity instruments that are considered to be strategic investments as financial assets at fair value through other comprehensive income. The fair value of such investments amounted to $38,361, $38,461 and $71,545 as at June 30, 2024, December 31, 2023, and June 30, 2023, respectively.

  • B. Amounts recognised in other comprehensive income in relation to the financial assets at fair value through other comprehensive income (loss) amounted to ($1,102), $1,974, ($4,400) and $1,658 for the three-month and six-month periods ended June 30, 2024 and 2023, respectively.

  • C. The Group has no financial assets at fair value through other comprehensive income as at June 30, 2024, December 31, 2023, and June 30, 2023, pledged to others.

~15~

(4) Financial assets at amortised cost

Financial assets at amortised cost
Items
Current items:
Time deposit with maturity from
three months to one year
Non-current items:
Corporate bonds
Time deposit with maturity over
one year
June 30,2024
December31,2023
2,417,635
$ 390,169
$ 283,513
$ -
$ 1,229,374
1,083,803
1,512,887
$ 1,083,803
$
June 30,2023
387,860
$
-
$ 948,103
948,103
$
  • A. Amounts recognised in profit or loss in relation to financial assets at amortised cost are listed below:
below:
Interest income
Interest income
Three-month
period ended June 30,2024
36,043
$ Six-month
period ended June 30,2024
58,141
$
Three-month
period ended June 30,2023
9,645
$
Six-month
period ended June 30,2023
17,623
$
  • B. The Group has no financial assets at amortised cost pledged to others.

  • C. Information relating to credit risk of financial assets at amortised cost is provided in Note 12(2). The counterparties of the Group’s investments in time deposits are financial institutions with high credit quality, so the Group expects that the probability of counterparty default is remote.

(5) Notes and accounts receivable

Notes receivable
Accounts receivable
Less: Loss allowance
June 30,2024
December31,2023
36,001
$ 28,796
$ 1,104,426
$ 1,742,473
$ 395)
(
1,466)
(
(
1,104,031
$ 1,741,007
$
June 30,2023
46,726
$ 1,624,846
$ 694)

1,624,152
$

~16~

A. The ageing analysis of notes and accounts receivable based on past due date is as follows:

Not past due
Up to 30 days
31 to 90 days
91 to 180 days
181 to 360 days
Notes
Accounts
receivable
receivable
36,001
$ 1,050,378
$ -
52,063
-
1,178
-
807
-
-
36,001
$ 1,104,426
$ June 30,2024
December Accounts
receivable
1,449,054
$ 282,269
10,260
208
682
1,742,473
$ 31,2023
June 30,2023 June 30,2023
Notes
receivable
36,001
$ -
-
-
-
36,001
$
Notes
receivable
28,796
$ -
-
-
-
28,796
$
Notes
receivable
46,726
$ -
-
-
-
46,726
$
Accounts
receivable
1,408,269
$ 194,519
21,851
207
-
1,624,846
$

The above ageing analysis was based on past due date.

  • B. As of June 30, 2024, December 31, 2023, and June 30, 2023, accounts receivable were all from contracts with customers. And as of January 1, 2023, the balance of accounts receivable from contracts with customers amounted to $2,179,250.

  • C. The Group’s notes receivable and accounts receivable do not hold any collateral provided by customers.

  • D. As at June 30, 2024, December 31, 2023, and June 30, 2023, without taking into account any collateral held or other credit enhancements, the maximum exposure to credit risk in respect of the amount that best represents the Group’s notes and accounts receivable was $36,001, $28,796 and $46,726; $1,104,031, $1,741,007 and $1,624,152, respectively.

  • E. Information relating to credit risk of notes and accounts receivable are provided in Note 12(2).

(6) Inventories

Raw materials
Work in progress
Finished goods
Total
Raw materials
Work in progress
Finished goods
Total
June 30,2024
Cost
1,155,500
$ 243,815
195,338
1,594,653
$
Allowance for
valuation loss
43,510)
($ 28,737)
(
11,295)
(
83,542)
($ December31,2023
Bookvalue
1,111,990
$ 215,078
184,043
1,511,111
$
Cost
1,201,372
$ 301,734
340,901
1,844,007
$
Bookvalue
1,152,653
$ 279,778
329,678
1,762,109
$

~17~

Raw materials
Work in progress
Finished goods
Total
June 30,2023
Cost
1,304,761
$ 321,687
224,298
1,850,746
$
Allowance for
valuation loss
24,822)
($ 7,762)
(
9,366)
(
41,950)
($
Bookvalue
1,279,939
$ 313,925
214,932
1,808,796
$

The cost of inventories recognised as expense for the period:

Cost of goods sold and others
(Gain on reversal of) loss on decline in
market value
Total
Cost of goods sold and others
(Gain on reversal of) loss on decline in
market value
Total
Three-month
period ended June 30,2024
1,147,475
$ 12,390
(
1,159,865
$ Six-month
period ended June 30,2024
2,272,524
$ 1,644
(
2,274,168
$
Three-month
period ended June 30,2023
1,652,545
$ 5,077)

1,647,468
$ Six-month
period ended June 30,2023
3,420,144
$ 23,441)

3,396,703
$

For the three-month and six-month periods ended June 30, 2023, the Group reversed a previous inventory write-down and accounted for as reduction of cost of goods sold because inventory that has been appropriated as loss on decline in market value was partially sold.

(Blank below)

~18~

(7) Property, plant and equipment

At January 1
Cost
Accumulated depreciation
At January 1
Additions
Reclassifications
Depreciation charge
Net exchange differences
At June 30
At June 30
Cost
Accumulated depreciation
2024

~19~

2023

At January 1
Cost
Accumulated depreciation
At January 1
Additions
Reclassifications
Depreciation charge
Net exchange differences
At June 30
At June 30
Cost
Accumulated depreciation
Construction in
progress and
Buildings and
equipment to
Land
structures
Machinery
Test equipment
be inspected
Others
Total
468,684
$ 2,768,758
$ 1,102,114
$ 138,366
$ 25,538
$ 398,066
$ 4,901,526
$ -
896,745)
(
845,228)
(
126,535)
(
-
370,685)
(
2,239,193)
(
468,684
$ 1,872,013
$ 256,886
$ 11,831
$ 25,538
$ 27,381
$ 2,662,333
$ 468,684
$ 1,872,013
$ 256,886
$ 11,831
$ 25,538
$ 27,381
$ 2,662,333
$ -
123
1,846
473
40,222
3,558
46,222
7,599
1,825
4,684
344
6,964)
(
-
7,488
-
34,948)
(
37,233)
(
2,256)
(
-
4,900)
(
79,337)
(
-
15,486)
(
4,947)
(
24)
(
742)
(
351)
(
21,550)
(
476,283
$ 1,823,527
$ 221,236
$ 10,368
$ 58,054
$ 25,688
$ 2,615,156
$ 476,283
$ 2,745,304
$ 1,085,169
$ 137,557
$ 58,054
$ 260,181
$ 4,762,548
$ -
921,777)
(
863,933)
(
127,189)
(
-
234,493)
(
2,147,392)
(
476,283
$ 1,823,527
$ 221,236
$ 10,368
$ 58,054
$ 25,688
$ 2,615,156
$
  • A. For the six-month periods ended June 30, 2024 and 2023, there was no capitalisation of borrowing costs attributable to the property, plant and equipment.

B. Information about the property, plant and equipment that were pledged to others as collaterals is provided in Note 8.

~20~

- (8) Leasing arrangements lessee

  • A. The Group leases various assets including land, buildings, and business vehicles, the duration of the building and the business vehicles lease contract is usually between 1 and 5 years, the duration of the land lease contract usually between 20 and 49 years. Lease agreements are negotiated on an individual basis and contain a wide range of different terms and conditions. The lease agreements do not impose covenants, but leased assets may not be used as security for borrowing purposes.

  • B. Short-term leases with a lease term of 12 months or less comprise of buildings and equipment. Low-value assets comprise of copy machines, etc.

  • C. The carrying amount and depreciation charge are as follows:

June 30,2024
December31,2023
June 30,2023
Land
98,505
$ 99,502
$ 101,259
$ Buildings
37,363
44,784
53,236
Transportation equipment
(Business vehicles)
-
-
574
135,868
$ 144,286
$ 155,069
$ Carryingamount
Three-month
Three-month
period ended
period ended
June 30,2024
June 30,2023
Land
939
$ 933
$ Buildings
4,429
3,861
Transportation equipment (Business vehicles)
-
859
5,368
$ 5,653
$ Six-month
Six-month
period ended
period ended
June 30,2024
June 30,2023
Land
1,873
$ 1,868
$ Buildings
8,763
6,616
Transportation equipment (Business vehicles)
-
1,720
10,636
$ 10,204
$ Depreciationcharge
Depreciationcharge
Carryingamount Carryingamount
June 30,2023
101,259
$ 53,236
574
155,069
$
Three-month
Three-month
period ended
period ended
June 30,2024
June 30,2023
939
$ 933
$ 4,429
3,861
-
859
5,368
$ 5,653
$ Depreciationcharge
Three-month
period ended
June 30,2023
933
$ 3,861
859
5,653
$
Six-month
period ended
June 30,2024
1,873
$ 8,763
-
10,636
$
Six-month
period ended
June 30,2023
1,868
$ 6,616
1,720
10,204
$
  • D. For the three-month and six-month periods ended June 30, 2024 and 2023, the additions to rightof-use assets were $0, $31,174, $0 and $37,682, respectively.

~21~

E. The information on profit and loss accounts relating to lease agreements is as follows:

Items affecting profit or loss
Interest expense on lease liabilities
Expense on short-term lease agreements
Expense on leases of low-value assets
Items affecting profit or loss
Interest expense on lease liabilities
Expense on short-term lease agreements
Expense on leases of low-value assets
Three-month
period ended
June 30,2024
617
$
1,068
50
Six-month
period ended
June 30,2024
1,246
$
1,904
109
Three-month
period ended
June 30,2023
567
$ 1,418
64
Six-month
period ended
June 30,2023
907
$ 2,710
157
  • F. For the six-month periods ended June 30, 2024 and 2023, the Group’s total cash outflow for leases were $13,042 and $12,918, respectively.

  • G. Extension and termination options

In determining the lease term, the Group takes into consideration all facts and circumstances that create an economic incentive to exercise an extension option. The assessment of lease period is reviewed if a significant event occurs which affects the assessment.

(9) Investment property

nvestment property
2024
Land Buildings and structures Total
At January 1
Cost $ 587,193
$ 1,048,977
$ 1,636,170
Accumulated depreciation ( 4,743)
( 304,964)
( 309,707)
$ 582,450 $ 744,013 $ 1,326,463
At January 1 $ 582,450
$ 744,013
$ 1,326,463
Depreciation charge ( 153)
( 12,752)
( 12,905)
Net exchange differences 447 29,097 29,544
At June 30 $ 582,744 $ 760,358 $ 1,343,102
At June 30
Cost $ 587,880
$ 1,089,389
$ 1,677,269
Accumulated depreciation ( 5,136)
( 329,031)
( 334,167)
$ 582,744 $ 760,358 $ 1,343,102

~22~

2023

2023 2023
Land Buildingsand structures Total
At January 1
Cost $ 587,427
$ 1,062,736
$ 1,650,163
Accumulated depreciation ( 4,522)
( 283,594)
( 288,116)
$ 582,905 $ 779,142 $ 1,362,047
At January 1 $ 582,905
$ 779,142
$ 1,362,047
Depreciation charge ( 151)
( 12,596)
( 12,747)
Net exchange differences ( 209)
( 13,593)
( 13,802)
At June 30 $ 582,545 $ 752,953 $ 1,335,498
At June 30
Cost $ 587,112
$ 1,044,222
$ 1,631,334
Accumulated depreciation ( 4,567)
( 291,269)
( 295,836)
$ 582,545 $ 752,953 $ 1,335,498
  • A. Rental income from investment property and direct operating expenses arising from investment property are shown below:
Rental income from investment property
Direct operating expenses arising from the
investment property that generated rental income
during the period
Rental income from investment property
Direct operating expenses arising from the
investment property that generated rental income
during the period
Three-month
period ended
June 30,2024
28,732
$ 9,323
$ Six-month
period ended
June 30,2024
56,958
$ 18,512
$
Three-month
period ended
June 30,2023
24,339
$
8,686
$
Six-month
period ended
June 30,2023
49,022
$
17,490
$
  • B. The fair value of the investment property held by the Group as at June 30, 2024, December 31, 2023, and June 30, 2023, amounted to $1,811,114, $1,800,394 and $1,838,038, respectively, which were valued by independent appraisers. Valuations were made using the comparative method and income approach to perform evaluation capitalisation.

  • C. There was no capitalisation of borrowing costs attributable to investment property.

  • D. Information about the investment property that was pledged to others as collateral is provided in Note 8.

~23~

(10) Intangible assets

2024 2023
At January 1
Cost $ 638,166
$ 742,377
Accumulated amortisation ( 473,377)
( 428,874)
$ 164,789 $ 313,503
At January 1 $ 164,789
$ 313,503
Additions 4,983 36,725
Reclassifications 28,007 -
Amortisation charge ( 20,095)
( 78,602)
Net exchange differences 4,249 739
At June 30 $ 181,933 $ 272,365
At June 30
Cost $ 261,965
$ 556,881
Accumulated amortisation ( 80,032)
( 284,516)
$ 181,933 $ 272,365
A. Details of amortisation on intangible assets are as follows:
Three-month Three-month
period ended June 30,2024 period ended June 30,2023
Operating costs $ 155
$ 149
Operating expenses 10,837 39,487
$ 10,992 $ 39,636
Six-month Six-month
period ended June 30,2024 period ended June 30,2023
Operating costs $ 305
$ 307
Operating expenses 19,790 78,295
$ 20,095 $ 78,602

B. The Group has no intangible assets pledged to others.

(11) Short-term borrowings

Short-term borrowings
Type ofborrowings
Bank borrowings
Unsecured borrowings
Type ofborrowings
Bank borrowings
Unsecured borrowings
Type ofborrowings
Bank borrowings
Unsecured borrowings
June 30,2024
1,617,044
$ December31,2023
2,234,704
$ June 30,2023
2,244,191
$
Interest raterange
1.78% ~ 2.90%
Interest raterange
1.74%~3.10%
Interest raterange
1.75%~3.10%
Collateral
None
Collateral
None
Collateral
None

~24~

(12) Short-term notes and bills payable

June 30, 2024 December31,2023 December31,2023 December31,2023 June 30,2023 June 30,2023
Commercial paper payable $ -
$ -
$ 100,000
Less: Discount on short-term
notes and bills payable - - ( 66)
$ - $ - $ 99,934
Interest rate range - - 1.80%~1.90%
Long-term borrowings
Interest
Type ofborrowings Borrowing period rate range Collateral June 30,2024
Bank secured borrowings June 9, 2023 to June 9, 1.9%~2.0% Note $ 900,000
2025
Less: Current portion ( 900,000)
$ -
Interest
Type ofborrowings Borrowing period rate range Collateral December31,2023
Bank secured borrowings June 9, 2023 to June 9, 1.9%~2.0% Note $ 900,000
2025
Less: Current portion -
$ 900,000
Interest
Type ofborrowings Borrowing period rate range Collateral June 30,2023
Bank secured borrowings June 9, 2023 to June 9, 1.9%~2.0% Note $ 900,000
2025
Less: Current portion -
$ 900,000

- (13) Long term borrowings

Note:For details of the collateral of long-term borrowings, please refer to Note 8.

~25~

(14) Other payables

Accrued salaries and bonus
Cash dividends payable
Employees’ and directors’
compensation payable
Royalty payable
Taxes payable
Insurance premiums and
pensions payable
Service fee payable
Interest payable
Payable on equipment
Payable on intangible assets
Other
June 30,2024
December31,2023
183,246
$ 267,240
$ 193,697
-
301,068
346,960
1,225
1,189
31,443
29,487
14,709
16,068
68,847
75,240
2,991
2,492
17,364
329
43,772
42,618
141,216
135,879
999,578
$ 917,502
$
June 30,2023
185,779
$ 276,728
269,313
1,254
34,997
16,316
56,877
3,756
2,844
44,251
123,138
1,015,253
$

(15) Pensions

  • A. (a) The Company has a defined benefit pension plan in accordance with the Labor Standards Act, covering all regular employees’ service years prior to the enforcement of the Labor Pension Act on July 1, 2005 and service years thereafter of employees who chose to continue to be subject to the pension mechanism under the Labor Standards Act. Under the defined benefit pension plan, two units are accrued for each year of service for the first 15 years and one unit for each additional year thereafter, subject to a maximum of 45 units. Pension benefits are based on the number of units accrued and the average monthly salaries and wages of the last 6 months prior to retirement. The company contributes monthly an amount equal to 2% of the employees’ monthly salaries and wages to the retirement fund deposited with Bank of Taiwan, the trustee, under the name of the independent retirement fund committee.

  • (b) For the aforementioned pension plan, the Group recognised pension costs of $0, $0, $40 and

    • $64 for the three-month and six-month periods ended June 30, 2024 and 2023, respectively.
  • (c) Expected contributions to the defined benefit pension plans of the Company for the year ending December 31, 2024 amount to $1,385.

  • B.(a) Effective July 1, 2005, the Company and its domestic subsidiaries have established a defined contribution pension plan (the “New Plan”) under the Labor Pension Act, covering all regular employees with R.O.C. nationality. Under the New Plan, the Company and its domestic subsidiaries contribute monthly an amount based on 6% of the employees’ monthly salaries and wages to the employees’ individual pension accounts at the Bureau of Labor Insurance. The benefits accrued are paid monthly or in lump sum upon termination of employment. The pension costs under defined contribution pension plans of the Group for the three-month and six-month periods ended June 30, 2024 and 2023, were $7,379, $8,025, $14,922 and $16,341,

~26~

respectively, under the above pension scheme.

  • (b) The foreign subsidiaries provided defined contribution plans for their employees. Pursuant to local regulations, such employees and the subsidiaries each make contributions based on a certain percentage based of the salaries and wages to the pension funds. The subsidiaries had recognised pension costs of $6,873, $6,079, $13,439 and $12,725, for the three-month and six-month periods ended June 30, 2024 and 2023, respectively.

(16) Share-based payments

  • A. For the six-month periods ended June 30, 2024 and 2023, the Group’s share-based payment arrangements were as follows:
Type of arrangement Grant date Quantity
granted
(share in
thousands)
Contract
period
Vesting
conditions
Plan for restricted shares to
employee (2018-1)
Plan for restricted shares to
employee (2019-1)
"
January 20, 2020
January 20, 2020
April 24, 2020
2,196
2,030
86
3 years
3 years
3 years
Note
Note
Note
  • Note: The restricted shares were issued at no consideration to the Company’s existing employees whose service years have reached 1 year, 2 years and 3 years and who achieved the performance condition. The vested ratio is 40%, 30% and 30%, respectively. If employees who are entitled to receive restricted shares do not meet the vesting conditions, the Company will retrieve at no consideration and retire those shares. The shares and dividends distributed to employees during the vesting period shall be given by the Company at no consideration. Employees are not required to return the shares and dividends if they resign during the vesting period.

  • B. Restricted shares to employees:

The information on restricted shares to employees is as follows (share in thousands): For the six-month period ended June 30, 2024: None.

2023
Shares not vested beginning balance 912
Shares vested ( 894)
Shares forfeited - retired ( 18)
Shares not vested ending balance -

~27~

  • C. The information of fair value of the share-based payment transaction given by the Group is as follows:
follows:
Type of arrangement Grant date Share price
(in NT dollar)
Exercise
price
(in NT
dollar)
Expected
price
volatility
Expected
option life
Expected
dividends
Risk-free
interest
rate
Weighted
average
fair value
per unit
(in NT dollar)
Plan for restricted
shares to employee
(2018-1)
Plan for restricted
shares to employee
(2019-1)
"
January 20, 2020
January 20, 2020
April 24, 2020
22.80
$ 22.80
18.20
-
$ -
-
N/A
N/A
N/A
3 years
3 years
3 years
N/A
N/A
N/A
N/A
N/A
N/A
22.80
$ 22.80
18.20
  • D. For the six-month periods ended June 30, 2024 and 2023, the subsidiary, Altek Medical Pte. Ltd.’s ( Altek Medical Holding (Cayman) Co., Ltd. relocated to Singapore and changed its name to Altek Medical Pte. Ltd.). Share-based payment arrangements were as follows:
Type of arrangement Grantdate Quantity
granted
(share in
thousands)
Contract
period
Vesting
conditions
Plan for restricted shares to
employee
Plan for restricted shares to
employee
Plan for restricted shares to
employee
November 2, 2021
Octorber 2, 2023
May 3, 2024
3,166
2,000
6,500
3 years
3 years
3 years
Note
Note
Note

Note: Employees have to pay to acquire those shares. The vesting condition is 1 to 3 years’ services or become vested under certain conditions.

The share-based payment transaction used the Black-Scholes option valuation model to estimate the fair value of the option. For the period from January 1 to June 30, 2024, the weighted average fair value of the Plan for restricted shares to employee granted was $0.1(in US dollars).

E. Expenses incurred on share-based payment transactions are shown below:

Equity-settled
Equity-settled
Three-month
period ended June 30,2024
15,102
$ Six-month
period ended June 30,2024
15,102
$
Three-month
period ended June 30,2023
-
$
Six-month
period ended June 30,2023
285
$

~28~

(17) Provisions

Provisions
At January 1, 2024
Additional provisions
Reversed during the period
Exchange differences
At June 30, 2024
Current
Non-current
$ (
$ June 30,2024
December31,2023
74,099
$ 67,256
$ 124,032
$ 130,998
$
Warranty
2024
198,254

7,800
8,107)

184
198,131
June 30,2023
58,885
$ 135,009
$

The Group provides warranties on digital image technology application products sold. Provision for warranties is estimated based on historical warranty data of digital image technology application products.

(18) Share capital

As of June 30, 2024, the Company’s authorised capital was $5,000,000, consisting of 500,000 thousand shares of ordinary stock, and the paid-in capital was $2,788,000 with a par value of $10 (in NT dollars) per share.

A. Movements in the number of the Company’s ordinary shares outstanding are as follows (share in thousands):

At January 1
Retired restricted shares to employees that
did not meet the vesting conditions
At June 30
2024
276,710
-
(
276,710
2023
276,728
18)

276,710

B. Treasury shares

(a) Reason for share reacquisition and the number of the Company’s treasury shares are as follows :

follows :
Name of company
holdingthe shares
Reason for reacquisition Number of shares
(share in thousands)
Carrying amount
2,090
38,101
$ June 30,2024
Number of shares
(share in thousands)
Carryingamount
2,090
38,101
$ December31,2023
June 30,2024
Carrying amount
The Company
Name of company
holdingthe shares
To be reissued to employees
Reason for reacquisition
38,101
$
31,2023
Carryingamount
The Company To be reissued to employees 38,101
$

~29~

June 30, 2023

Name of company
holdingthe shares
Reason for reacquisition Number of shares
(share in thousands)
2,090
Carryingamount
The Company To be reissued to employees 38,101
$
  • (b) Pursuant to the R.O.C. Securities and Exchange Act, the number of shares bought back as treasury share should not exceed 10% of the number of the Company’s issued and outstanding shares and the amount bought back should not exceed the sum of retained earnings, paid-in capital in excess of par value and realised capital surplus.

  • (c) Pursuant to the R.O.C. Securities and Exchange Act, treasury shares should not be pledged as collateral and is not entitled to dividends before it is reissued.

(d) Pursuant to the R.O.C. Securities and Exchange Act, treasury shares should be reissued to the employees within five years from the reacquisition date and shares not reissued within the five-year period are to be retired.

(19) Capital surplus

Pursuant to the R.O.C. Company Act, capital surplus arising from paid-in capital in excess of par value on issuance of common stocks and donations can be used to cover accumulated deficit or to issue new shares or cash to shareholders in proportion to their share ownership, provided that the Company has no accumulated deficit. Further, the R.O.C. Securities and Exchange Act requires that the amount of capital surplus to be capitalised mentioned above should not exceed 10% of the paidin capital each year. Capital surplus should not be used to cover accumulated deficit unless the legal reserve is insufficient.

reserve is insufficient.
At January 1
Changes in ownership
interests in subsidiaries
At June 30
At January 1
Employee restricted shares vested
Reired restricted shares to
employees that did not meet
the vesting conditions
At June 30
2024
Sharepremium
1,925,458
$ -
1,925,458
$
Changes in
ownership
interests in
subsidiaries
Treasuryshares
-
$ 120,936
$ 6,780
-
6,780
$ 120,936
$ 2023
Sharepremium
1,914,073
$ 11,385
-
1,925,458
$
Treasuryshares
120,936
$ -
-
120,936
$

~30~

(20) Retained earnings

  • A. According to the Company’s Articles of Incorporation, the annual earnings, if any, shall first be used to pay all taxes and offset prior years’ operating losses and then 10% of the remaining amount shall be set aside as legal reserve. Special reserve shall be set aside in accordance with the relevant regulations. The remaining amount plus the unappropriated earnings of prior years are distributed in cash, based on the resolution by the Board of Directors. In the case of new shares, the distribution shall be proposed by the Board of Directors and resolved at the shareholders’ meeting.

  • Dividends and bonus, in the form of cash, could be resolved by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors and reported at the shareholders’ meeting.

  • B. The amount of dividends appropriated is based on the Company’s current year’s net income and prior years’ retained earnings, taking into account the Company’s financial structure and future operating plans. The distribution ratio of cash dividends to stock dividends is based on the Company’s funding status, diluted earnings per share and other factors. According to the dividend policy, cash dividends shall account for at least 20% of the total dividends distributed.

  • C. Except for covering accumulated deficit or issuing new shares or cash to shareholders in proportion to their share ownership, the legal reserve shall not be used for any other purpose. The use of legal reserve for the issuance of shares or cash to shareholders in proportion to their share ownership is permitted, provided that the balance of the reserve exceeds 25% of the Company’s paid-in capital.

  • D. (a) In accordance with the regulations, the Company shall set aside special reserve from the debit balance on other equity items at the balance sheet date before distributing earnings. When debit balance on other equity items is reversed subsequently, the reversed amount could be included in the distributable earnings.

  • (b) The amounts previously set aside by the Company as special reserve on initial application of IFRSs in accordance with Order No. Financial-Supervisory-Securities-Corporate1010012865, dated April 6, 2012, shall be reversed proportionately when the relevant assets are used, disposed of or reclassified subsequently. Such amounts are reversed upon disposal or reclassified if the assets are investment property of land, and reversed over the use period if the assets are investment property other than land.

~31~

E. The appropriation of 2023 and 2022 earnings had been resolved at the shareholders’ meeting on June 13, 2024 and June 21, 2023. Details are summarised below:

Legal reserve
(Reversal of)
special reserve
Cash dividends
Dividends per share
Dividends per share
Amount
(inNTdollars)
Amount
(inNTdollars)
27,926
$ 43,676
$ 108,904
259,420)
(
193,697
0.7
$ 276,728
1.0
$ 330,527
$ 60,984
$ 2023
2022
2022 2022
Amount
27,926
$ 108,904
193,697
330,527
$
Dividends per share
(inNTdollars)
1.0
$

The appropriation of 2023 and 2022 earnings were the same as that proposed by the Board of Directors on March 11, 2024 and March 10, 2023, respectively.

(21) Other equity items

Unrealised
Foreign currency
losses on
translation
valuation
Total
At January 1
445,272)
($ 179,044)
($ 624,316)
($ Valuation adjustment
-
4,400)
(
4,400)
(
Currency translation differences:
-Group
399,882
-
399,882
At June 30
45,390)
($ 183,444)
($ 228,834)
($ 2024
Unrealised
Foreign currency
losses on
Unearned
translation
valuation
compensation
Total
At January 1
367,270)
($ 148,141)
($ 696)
($ 516,107)
($ Valuation adjustment
-
1,658
-
1,658
Currency translation differences:
-Group
66,552)
(
-
-
66,552)
(
Retirement of restricted shares
to employees
-
-
411
411
Share-based payment transactions
-
-
285
285
At June 30
433,822)
($ 146,483)
($ -
$ 580,305)
($ 2023
2024 Total
624,316)

4,400)

399,882
228,834)
Total

~32~

(22) Operating revenue

Operating revenue
Revenue from contracts with customers
Revenue from contracts with customers
Three-month
period ended
June 30,2024
1,704,446
$ Six-month
period ended
June 30,2024
3,304,288
$
Three-month
period ended
June 30,2023
2,208,835
$
Six-month
period ended
June 30,2023
4,462,412
$

A. Disaggregation of revenue from contracts with customers

The Group derives revenue from the transfer of goods and services over time and at a point in time in the following major geographical regions:

Three-month
period ended
June 30,2024
Revenue from external
customer contracts
Timing of revenue
recognition
At a point in time
Over time
Total
Three-month
period ended
June 30,2023
Revenue from external
customer contracts
Timing of revenue
recognition
At a point in time
Over time
Total
Six-month
period ended
June 30,2024
Revenue from external
customer contracts
Timing of revenue
recognition
At a point in time
Over time
Total
Asia
789,720
$ 769,594
$ 20,126
789,720
$ Asia
1,078,547
$ 1,007,718
$ 70,829
1,078,547
$ Asia
1,397,132
$ 1,325,576
$ 71,556
1,397,132
$
Europe
309,806
$ 274,369
$ 35,437
309,806
$ Europe
447,179
$ 436,763
$ 10,416
447,179
$ Europe
779,026
$ 739,521
$ 39,505
779,026
$
America
604,499
$ 491,428
$ 113,071
604,499
$ America
683,109
$ 664,289
$ 18,820
683,109
$ America
1,127,546
$ 943,210
$ 184,336
1,127,546
$
Taiwan
421
$ 420
$ 1
421
$ Taiwan
-
$ -
$ -
-
$ Taiwan
584
$ 420
$ 164
584
$
Total
1,704,446
$
1,535,811
$ 168,635
1,704,446
$
Total
2,208,835
$
2,108,770
$ 100,065
2,208,835
$
Total
3,304,288
$
3,008,727
$ 295,561
3,304,288
$

~33~

Six-month
period ended
June 30,2023
Revenue from external
customer contracts
Timing of revenue
recognition
At a point in time
Over time
Total
Asia
2,194,581
$ 2,087,494
$ 107,087
2,194,581
$
Europe
823,790
$ 765,005
$ 58,785
823,790
$
America
1,438,959
$ 1,366,959
$ 72,000
1,438,959
$
Taiwan
5,082
$ 3,511
$ 1,571
5,082
$
Total
4,462,412
$
4,222,969
$ 239,443
4,462,412
$

B. Contract liabilities

The Group has recognised the following revenue-related contract liabilities:

Contract
liabilities
June 30,2024
December31,2023
191,253
$ 351,051
$
June 30,2023
455,805
$
January1,2023
439,481
$

C. Revenue recognised that was included in the contract liabilities at the beginning of the period

Interest income
Revenue recognised that was included in the
contract liabilities at the beginning of the period
Revenue recognised that was included in the
contract liabilities at the beginning of the period
Interest income from bank deposits
Interest income from financial assets measured at
amortised cost
Other interest income
Three-month
period ended
June 30,2024
71,332
$ Six-month
period ended
June 30,2024
223,621
$ Three-month
period ended
June 30,2024
20,269
$ 36,043
-
56,312
$
Three-month
period ended
June 30,2023
74,961
$
Six-month
period ended
June 30,2023
154,451
$
Three-month
period ended
June 30,2023
45,200
$ 9,645
13
54,858
$

(23) Interest income

~34~

(24)
(25)
Other income
Other gains and losses
Six-month
Six-month
period ended
period ended
June 30,2024
June 30,2023
Interest income from bank deposits
46,305
$ 73,903
$ Interest income from financial assets measured at
amortised cost
58,141
17,623
Other interest income
1
27
104,447
$ 91,553
$ Three-month
Three-month
period ended
period ended
June 30,2024
June 30,2023
Rent income
18,549
$ 14,172
$ Other income - others
5,471
11,480
24,020
$ 25,652
$ Six-month
Six-month
period ended
period ended
June 30,2024
June 30,2023
Rent income
36,890
$ 29,088
$ Other income - others
12,930
19,013
49,820
$ 48,101
$ Three-month
Three-month
period ended
period ended
June 30,2024
June 30,2023
Gain on disposal of property, plant and
equipment
17
$ -
$ Net currency exchange (losses) gains
885)
(
4,167
Net loss on financial assets at fair
value through profit or loss
519)
(
12,691)
(
Other expenses
5,371)
(
167)
(
6,758)
($ 8,691)
($

~35~

Six-month Six-month
period ended period ended
June 30,2024 June 30,2023
Gain on disposal of property, plant and $ 17
$ 11
equipment
Net currency exchange gains (losses) 13,217 ( 2,039)
Net loss on financial assets at fair
value through profit or loss ( 549)
( 6,860)
Other expenses ( 10,930)
( 363)
$ 1,755 ($ 9,251)
Finance costs
Three-month Three-month
period ended period ended
June 30,2024 June 30,2023
Interest expense :
Bank loan $ 12,582
$ 15,653
Lease liabilities 617 567
Other - 459
$ 13,199 $ 16,679
Six-month Six-month
period ended period ended
June 30,2024 June 30,2023
Interest expense :
Bank loan $ 27,368
$ 29,778
Lease liabilities 1,246 907
Other - 2,280
$ 28,614 $ 32,965
Expenses by nature
Three-month Three-month
period ended period ended
June 30,2024 June 30,2023
Employee benefit expenses $ 404,225
$ 373,086
Depreciation charges on property, plant and
equipment 30,559 37,999
Depreciation charges on right-of-use assets 5,368 5,653
Depreciation charges on investment property 6,520 6,341
Amortisation charges on intangible assets 10,992 39,636

(26) Finance costs

(27) Expenses by nature

~36~

Employee benefit expenses
Employee benefit expenses
Depreciation charges on property, plant and
equipment
Depreciation charges on right-of-use assets
Depreciation charges on investment property
Amortisation charges on intangible assets
Wages and salaries
Labour and health insurance fees
Pension costs
Other personnel expenses
Wages and salaries
Labour and health insurance fees
Pension costs
Other personnel expenses
Six-month
period ended
June 30, 2024
758,821
$ 60,010
10,636
12,905
20,095
Three-month
period ended
June 30,2024
363,543
$ 16,818
14,252
9,612
404,225
$ Six-month
period ended
June 30,2024
679,728
$ 31,866
28,401
18,826
758,821
$
Six-month
period ended
June 30, 2023
742,704
$ 79,337
10,204
12,747
78,602
Three-month
period ended
June 30,2023
333,017
$ 15,385
14,104
10,580
373,086
$
Six-month
period ended
June 30,2023
658,930
$ 33,116
29,130
21,528
742,704
$

(28) Employee benefit expenses

  • A. According to the Articles of Incorporation of the Company, employees’ compensation and directors’ remuneration shall be calculated based on current year’s earnings, which should first be used to cover accumulated deficit, if any, 10% to 20% for employees’ compensation and no more than 5% for directors’ remuneration. Employees’ compensation can be distributed in the form of shares or in cash. Employees of subsidiaries that the Company holds more than 50% shareholding are entitled to receive aforementioned shares or cash.

Abovementioned distributable profit of the current period refers to the pre-tax profit before deduction of employees’ compensation and directors’ remuneration. A company may, by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors, distribute employees’ compensation and directors’ remuneration and report such distribution to the shareholders’ meeting.

  • B. For the three-month and six-month periods ended June 30, 2024 and 2023, employees’ compensation was accrued at $15,319, $21,962, $31,457 and $35,827, respectively; directors’ remuneration was accrued at $5,107, $7,320, $10,486 and $11,942, respectively. The aforementioned amounts were calculated based on the Articles of Incorporation of the Company and recognised in salary expenses.

~37~

Employees’ compensation and directors’ remuneration for 2023 amounting to $76,140 and $25,380, respectively, as resolved at the meeting of Board of Directors were in agreement with those amounts recognised in the 2023 financial statements.

Information about employees’ compensation and directors’ remuneration of the Company as resolved at the meeting of Board of Directors will be posted in the “Market Observation Post System” at the website of the Taiwan Stock Exchange.

(29) Income tax

  • A. Income tax expense

  • (a) Components of income tax expense:

Current tax:
Current tax on profit for the period
Charge on unappropriated retained
earnings
Prior year income tax under (over)
estimation
Total current tax
Deferred tax:
Origination and reversal of temporary
differences
Income tax expense
Current tax:
Current tax on profit for the period
Charge on unappropriated retained
earnings
Tax paid outside of the territory of
the Republic of China
Prior year income tax over estimation
(
Total current tax
Deferred tax:
Origination and reversal of temporary
differences
(
Income tax expense
Three-month
period ended
June 30,2024
29,274
$ 1,047
2,556
(
32,877
13,731
(
46,608
$ Six-month
period ended
June 30,2024
92,534
$ 11,358
-
5,754)

(
98,138
4,883)

(
93,255
$
Three-month
period ended
June 30,2023
66,219
$ 21,902
1,901)

86,220
33,425)

52,795
$ Six-month
period ended
June 30,2023
104,785
$ 21,902
805
1,901)

125,591
41,968)

83,623
$

~38~

(b) The income tax charged to other comprehensive income is as follows:

Translation differences of foreign operations
Translation differences of foreign operations
Three-month
Three-month
period ended
period ended
June 30,2024
June 30,2023
21,763
$ 16,046)
($ Six-month
Six-month
period ended
period ended
June 30,2024
June 30,2023
99,970
$ 16,638)
($

B. The Company’s income tax returns through 2021 have been assessed and approved by the Tax Authority.

(30) Earnings per share

Earnings per share
Basic earnings per share
Profit attributable to ordinary
shareholders of the parent
Diluted earnings per share
Profit attributable to ordinary
shareholders of the parent
Assumed conversion of all dilutive
potential ordinary shares
Employees’ compensation
Profit attributable to ordinary
shareholders of the parent
plus assumed conversion of
all dilutive potential ordinary
shares
Three-monthperiod ended June 30,2024
Amount after tax
77,380
$ 77,380
$ -
77,380
$
Weighted average number of
ordinary shares outstanding
(share in thousands)
276,710
802
277,512
Earnings per share
(in dollars)
0.28
$
0.28
$

~39~

Basic earnings per share
Profit attributable to ordinary
shareholders of the parent
Diluted earnings per share
Profit attributable to ordinary
shareholders of the parent
Assumed conversion of all dilutive
potential ordinary shares
Restricted shares to employees
Employees’ compensation
Profit attributable to ordinary
shareholders of the parent
plus assumed conversion of
all dilutive potential ordinary
shares
Basic earnings per share
Profit attributable to ordinary
shareholders of the parent
Diluted earnings per share
Profit attributable to ordinary
shareholders of the parent
Assumed conversion of all dilutive
potential ordinary shares
Employees’ compensation
Profit attributable to ordinary
shareholders of the parent
plus assumed conversion of
all dilutive potential ordinary
shares
Three-monthperiod ended June 30,2023 Three-monthperiod ended June 30,2023 Three-monthperiod ended June 30,2023
Weighted average number of
ordinary shares outstanding
Earnings per share
Amount after tax
(share in thousands)
(in dollars)
91,969
$ 276,705
0.33
$ 91,969
$ -
5
-
1,082
91,969
$ 277,792
0.33
$ Six-monthperiod ended June 30,2024
Earnings per share
(in dollars)
0.33
$
0.33
$
Amount after tax
153,786
$ 153,786
$ -
153,786
$
Weighted average number of
ordinary shares outstanding
(share in thousands)
276,710
1,705
278,415
Earnings per share
(in dollars)
0.56
$
0.55
$

~40~

(31)
(32)
Transactions with non-controlling interest
Altek International Investment Co., Ltd. a subsidiary of the Group, repurchased shares from
shareholders of non-controlling interests in June 2023, thus increased the Group's shareholding ratio
by 28.57%.
The effect of changes in interests on the equity attributable to owners of the parent is shown below:
Supplemental cash flow information
A. Investing activities with partial cash payments:
Weighted average number of
ordinary shares outstanding
Earnings per share
Amount after tax
(share in thousands)
(in dollars)
Basic earnings per share
Profit attributable to ordinary
shareholders of the parent
158,325
$ 276,414
0.57
$ Diluted earnings per share
Profit attributable to ordinary
shareholders of the parent
158,325
$ Assumed conversion of all dilutive
potential ordinary shares
Restricted shares to employees
-
302
Employees’ compensation
-
2,055
Profit attributable to ordinary
shareholders of the parent
plus assumed conversion of
all dilutive potential ordinary
shares
158,325
$ 278,771
0.57
$ Six-monthperiod ended June 30,2023
Six-month
Six-month
period ended
period ended
June 30,2024
June 30,2023
Consideration paid to non-controlling
interests
-
$ 73,680)
($ Decrease in the carrying amount
of non-controlling interests
-
5,674
Capital surplus
-
$ 68,006)
($ Six-month
Six-month
period ended
period ended
June 30,2024
June 30,2023
Acquisition of property, plant, and equipment
58,637
$ 46,222
$ Add: Payable on equipment at beginning of
period
329
957
Less: Payable on equipment at end of period
17,364)
(
2,844)
(
Cash paid
41,602
$ 44,335
$

~41~

Acquisition of intangible assets
Add: Payables at beginning of period
Less: Payables at end of period
(
Cash paid
Six-month
period ended
June 30,2024
4,983
$ 42,618
43,772)

(
3,829
$
Six-month
period ended
June 30,2023
36,725
$ 10,686
44,251)

3,160
$

B. Financing activities with no cash flow effects:

Declaration of cash dividends

Six-month
period ended
June 30,2024
193,697
$
Six-month
period ended
June 30,2023
276,728
$

(33) Changes in liabilities from financing activities

January 1, 2024
Changes in cash
flow from financing
activities
Interest expenses
Declaration of cash
dividends
Other non-cash
items changes
Impact of changes
in foreign exchange
rate
June 30, 2024
Short-term
borrowings
Long-term
borrowings
(including
current
portion)
Guarantee
deposits
received
Lease
liabilities
Dividends
payable
Total
2,234,704
$ 622,609)
(
-
-
-
4,949
1,617,044
$
900,000
$ -
-
-
-
-
900,000
$
36,431
$ 45
-
-
-
1,504
37,980
$
132,175
$ 11,029)
(
1,246
-
35
1,385
123,812
$
-
$ -
-
193,697
-
-
193,697
$
3,303,310
$ 633,593)
(
1,246
193,697
35
7,838
2,872,533
$

~42~

January 1, 2023
Changes in cash
flow from financing
activities
Interest expenses
Declaration of cash
dividends
Other non-cash items
changes
Impact of changes
in foreign exchange
rate
June 30, 2023
Short-term
borrowings
Short-term
notes and
billspayable
Long-term
borrowings
(including
current
portion)
Guarantee
deposits
received
Lease
liabilities
Dividends
payable
Total
2,213,000
$ 33,261
-
-
-
2,070)
(
2,244,191
$
399,669
$ 302,015)
(
2,280
-
-
-
99,934
$
500,000
$ 400,000
-
-
-
-
900,000
$
36,422
$ 9)
(
-
-
-
676)
(
35,737
$
111,366
$ 10,051)
(
907
-
37,682
216)
(
139,688
$
-
$ -
-
276,728
-
-
276,728
$
3,260,457
$ 121,186
3,187
276,728
37,682
2,962)
(
3,696,278
$

7. RELATED PARTY TRANSACTIONS

(1) Names of related parties and relationship: None.

(2) Significant transactions and balances with related parties: No significant related party transactions. (3) Key management compensation

Key management compensation
Salaries and other short-term employee benefits
Post-employment benefits
Share-based payments
Total
Salaries and other short-term employee benefits
Post-employment benefits
Share-based payments
Total
Three-month
period ended
June 30,2024
51,368
$ 122
-
51,490
$ Six-month
period ended
June 30,2024
105,150
$ 283
-
105,433
$
Three-month
period ended
June 30,2023
12,578
$ 241
-
12,819
$
Six-month
period ended
June 30,2023
38,246
$ 483
78
38,807
$

~43~

8. PLEDGED ASSETS

The Group’s assets pledged as collateral are as follows:

Pledgedasset
Purpose
Land and
buildings
Medium and long-term
loans
Investment
property
Medium and long-term
loans
June 30,2024
December31,2023
209,489
$ 210,574
$ 727,090
730,387
936,579
$ 940,961
$ Bookvalue
June 30,2023
211,659
$ 733,683
945,342
$

9. SIGNIFICANT CONTINGENT LIABILITIES AND UNRECOGNISED CONTRACT

COMMITMENTS

None.

10. SIGNIFICANT DISASTER LOSS

None.

11. SIGNIFICANT EVENTS AFTER THE REPORTING PERIOD

None.

12. OTHERS

(1) Capital management

The Group’s objectives when managing capital are to safeguard the Group’s ability to continue as a going concern in order to provide returns for shareholders and to maintain an optimal capital structure to reduce the cost of capital. In order to maintain or adjust the capital structure, the Group may adjust the amount of dividends, return capital or issue new shares to achieve the optimal capital structure.

(2) Financial instruments

A. Financial instruments by category

Financial instruments by category
Financial assets
Financial assets at fair value through
profit or loss
Financial assets at fair value through
other comprehensive income
Financial assets at amortised cost
Cash and cash equivalents
Financial assets at amortised cost
Notes receivable
Accounts receivable
Other accounts receivable
Guarantee deposit paid
June 30,2024
December31,2023
125,403
$ 124,007
$ 38,361
$ 38,461
$ 3,772,714
$ 5,798,794
$ 3,930,522
1,473,972
36,001
28,796
1,104,031
1,741,007
109,452
68,885
34,345
35,953
8,987,065
$ 9,147,407
$
June 30,2023
107,600
$
71,545
$
6,062,081
$ 1,335,963
46,726
1,624,152
58,081
39,158
9,166,161
$

~44~

June 30, 2024 December 31, 2023 June 30, 2023

June 30,2024
December31,2023 June 30,2023
Financial liabilities
Financial liabilities at amortised cost
Short-term borrowings
Short-term notes and bills payable
Accounts payable
Other payables
Long-term borrowings
(including current portion)
Guarantee deposits received
Lease liabilities
1,617,044
$ -
1,044,253
999,578
900,000
37,980
4,598,855
$ 123,812
$
2,234,704
$ -
1,240,588
917,502
900,000
36,431
5,329,225
$ 132,175
$
2,244,191
$ 99,934
1,470,145
1,015,253
900,000
35,737
5,765,260
$
139,688
$
  • B. Financial risk management policies

  • (a) The Group’s activities expose it to a variety of financial risks: market risk (including foreign exchange risk, interest rate risk and price risk), credit risk and liquidity risk. The Group’s overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on the Group’s financial position and financial performance.

  • (b) Risk management is carried out by a Group treasury department under policies approved by the Board of Directors. Group treasury identifies, evaluates and hedges financial risks in close co-operation with the Group’s operating units. The Board provides written principles for overall risk management, as well as written policies covering specific areas and matters, such as foreign exchange risk, interest rate risk, credit risk, use of derivative financial instruments and non-derivative financial instruments, and investment of excess liquidity.

  • C. Significant financial risks and degrees of financial risks

  • (a) Market risk

Foreign exchange risk

  • i. The Group operates internationally and is exposed to exchange rate risk arising from the transactions of the Company and its subsidiaries used in various functional currency, primarily with respect to the USD and RMB. Exchange rate risk arises from future commercial transactions and recognised assets and liabilities.

  • ii. Exchange rate risk arises when future commercial transactions, recognised assets or liabilities are denominated in a foreign currency that is not the entity's functional currency. The Group's management has established a policy to its subsidiaries in the group to hedge its overall exchange rate risk through the Group’s finance department.

~45~

  • iii. The Group has certain investments in foreign operations, whose net assets are exposed to foreign currency translation risk. Currency exposure arising from the net assets of the Group’s foreign operations is managed primarily through transactions denominated in the relevant foreign currencies.

  • iv. The information on assets and liabilities denominated in foreign currencies whose values would be materially affected by the exchange rate fluctuations is as follows:

Foreign Currency
Amount
(In thousands)
(Foreign currency:
functional currency)
Financial assets
Monetary items
USD:NTD
36,862
USD
USD:RMB
32,798
USD
Financial liabilities
Monetary items
USD:NTD
33,109
USD
USD:RMB
27,608
USD
Foreign Currency
Amount
(In thousands)
(Foreign currency:
functional currency)
Financial assets
Monetary items
USD:NTD
52,681
USD
USD:RMB
39,257
USD
Financial liabilities
Monetary items
USD:NTD
47,198
USD
USD:RMB
34,250
USD
June 30, 2024 2024
Effect on
Effect on
Other
Exchange Book Value
Extent of
Profit or
Comprehensive
Rate
(NTD)
Variation
(Loss)
Income(Loss)
32.450
1,196,172
$ 1%
11,962
$ -
$ 7.1268
1,064,295
1%
10,643
-
32.450
1,074,387
$ 1%
10,744)
($ -
$ 7.1268
895,880
1%
8,959)
(
-
SensitivityAnalysis
December31,2023
SensitivityAnalysis
Effect on
Other
Comprehensive
Income(Loss)
-
$ -
-
$ -
Exchange
Rate
30.705
7.0827
30.705
7.0827
Book Value
(NTD)
1,617,570
$ 1,205,386
1,449,215
$ 1,051,646
SensitivityAnalysis
Effect on
Extent of
Profit or
Variation
(Loss)
1%
16,176
$ 1%
12,054
1%
14,492)
($ 1%
10,516)
(
Effect on
Other
Comprehensive
Income(Loss)
-
$ -
-
$ -


~46~

June 30, 2023

June 30, 2023 2023
Foreign Currency
Amount
(In thousands)
(Foreign currency:
functional currency)
Financial assets
Monetary items
USD:NTD
61,670
USD
USD:RMB
43,898
USD
Financial liabilities
Monetary items
USD:NTD
54,308
USD
USD:RMB
39,243
USD
Exchange
Rate
31.140
7.2258
31.140
7.2258
Book Value
(NTD)
1,920,404
$ 1,366,984
1,691,151
$ 1,222,027
SensitivityAnalysis
Effect on
Extent of
Profit or
Variation
(Loss)
1%
19,204
$ 1%
13,670
1%
16,912)
($ 1%
12,220)
(
Effect on
Other
Comprehensive
Income(Loss)
-
$ -
-
$ -


  • v. Total exchange gain (loss) including realised and unrealised arising from significant foreign exchange variation on the monetary items held by the Group for the three-month and six-month periods ended June 30, 2024 and 2023, amounted to ($885), $4,167, $13,217 and ($2,039), respectively.

Price risk

  • i. The Group’s investments in equity securities, which are exposed to price risk, are the held financial assets at fair value through profit or loss and financial assets at fair value through other comprehensive income.

  • ii. The Group’s investments in equity securities comprise shares issued by the domestic companies. The prices of equity securities would change due to the change of the future value of investee companies. If the prices of these equity securities had increased/decreased by 10% with all other variables held constant, post-tax profit for the and six-month periods ended June 30, 2024 and 2023 would have increased/decreased by $8,924 and $7,646, respectively, as a result of gains/losses on equity securities classified as at fair value through profit or loss. Other components of equity would have increased/decreased by $3,836 and $7,155, respectively, as a result of price change on equity investments at fair value through other comprehensive income.

Cash flow and fair value interest rate risk

The Group’s main interest rate risk arises from long-term and short-term borrowings. If the borrowing interest rate had increased/decreased by one yard with all other variables held constant, profit before tax for the six-month periods ended June 30, 2024 and 2023 would have increased/decreased by $3,146 and $3,930, respectively. The main factor is that changes in interest expense result in floating-rate borrowings.

~47~

(b) Credit risk

  • i. Credit risk refers to the risk of financial loss to the Group arising from default by customers or counterparties of financial instruments on the contract obligations. The main factor is that counterparties could not repay in full the accounts receivable based on the agreed terms.

  • ii. The Group manages their credit risk taking into consideration the entire Group’s concern. According to the Group’s credit policy, each local entity in the Group is responsible for managing and analysing the credit risk for each of their new customers before standard payment and delivery terms and conditions are offered. Internal risk control assesses the credit quality of the customers, taking into account their financial position, past experience and other factors. Individual risk limits are set based on internal or external ratings in accordance with limits set by the Board of Directors. The utilisation of credit limits is regularly monitored.

  • iii. The Group measured internal operating procedures, past experience of trading customers, and actual transaction status. If the contract payments were past due over 90 days based on the terms, there has been a significant increase in credit risk on that instrument since initial recognition. If the contract payments were past due over 360 days based on the term, the default has occurred.

  • iv. The following indicators are used to determine whether the credit impairment of debt instruments has occurred:

  • (i) It becomes probable that the issuer will enter bankruptcy or other financial reorganisation due to their financial difficulties;

  • (ii) The disappearance of an active market for that financial asset because of financial difficulties;

  • (iii) Default or delinquency in interest or principal repayments;

  • (iv) Adverse changes in national or regional economic conditions that are expected to cause a default.

  • v. The Group classifies customers’ accounts receivable, notes receivable and contract assets in accordance with customer types. The Group applies the simplified approach using loss provision matrix to estimate expected credit loss under the provision matrix basis.

  • vi. The Group wrote-off the financial assets, which cannot be reasonably expected to be recovered, after initiating recourse procedures. However, the Group will continue executing the recourse procedures to secure their rights.

~48~

vii. The Group used the forecastability to adjust historical and timely information to access the default possibility of contract assets, notes receivable and accounts receivable. As of June 30, 2024, December 31, 2023, and June 30, 2023, the provision matrix is as follows:

June 30,2024
Expected loss rate
Total book value
Loss allowance
December 31,2023
Expected loss rate
Total book value
Loss allowance
June 30,2023
Expected loss rate
Total book value
Loss allowance
Up to 90 days
past due
91 to180
days
past due
181 to 360
dayspast due
Over 361
days
Total
0.02% ~ 0.03%
1,139,620
$ 238
$ Up to 90 days
past due
15%~20%
807
$ 157
$ 91 to180
days
past due
30%~40%
-
$ -
$ 181 to 360
dayspast due
100%
-
$ -
$ Over 361
days
1,140,427
$ 395
$ Total
0.04%
1,770,379
$ 699
$ Up to 90 days
past due
15%~20%
208
$ 208
$ 91 to180
days
past due
30%~40%
682
$ 559
$ 181 to 360
dayspast due
100%
-
$ -
$ Over 361
days
1,771,269
$ 1,466
$ Total
0.03%~0.04%
1,671,365
$ 653
$
15%~20%
207
$ 41
$
30%~40%
-
$ -
$
100%
-
$ -
$
1,671,572
$ 694
$

viii. Movements in relation to the Group applying the simplified approach to provide loss allowance for contract assets and accounts receivable are as follows:

2024 2024 2024
Contract assets Accounts receivable
At January 1 $ -
$ 1,466
Reversal of impairment loss - ( 1,104)
Effect of foreign exchange - 33
At June 30 $ - $ 395
2023
Contract assets Accounts receivable
At January 1 $ 4
$ 454
(Reversal of) impairment loss ( 4)
242
Effect of foreign exchange - ( 2)
At June 30 $ - $ 694

ix. Movements in loss allowance for investments in debt instruments carried at amortised cost are as follows:

~49~

Financial assets at amortised cost
Group 1
Group 2
Financial assets at amortised cost
Group 1
Financial assets at amortised cost
Group 1
June 30,2024 June 30,2024 June 30,2024
12 months Lifetime Total
Significant
increase in
credit risk
Impairment of
credit
3,647,009
$ 283,513
3,930,522
$
-
$ -
-
$ 31,2023
3,647,009
$ 283,513
3,930,522
$
12 months Lifetime Total
Significant
increase in
credit risk
Impairment of
credit
1,473,972
$
1,473,972
$
12 months Lifetime Total
Significant
increase in
credit risk
Impairment of
credit
1,335,963
$
-
$
-
$
1,335,963
$

Group 1: Time deposits with an original maturity of more than three months from financial institutions with good credit quality.

Group 2: Standard Poor’s or Moody’s rating of A-level.

(c) Liquidity risk

  • i. Cash flow forecasting is performed in the operating entities of the Group and aggregated by Group treasury. Group treasury monitors rolling forecasts of the Group’s liquidity requirements to ensure it has sufficient cash to meet operational needs while maintaining sufficient headroom on its undrawn committed borrowing facilities. Such forecasting takes into consideration the Group’s debt financing plans, and compliance with internal balance sheet ratio targets.

~50~

  • ii. Surplus cash held by the operating entities over and above the balance required for working capital management are transferred to the Group treasury. Group treasury invests surplus cash in interest bearing current accounts, time deposits and marketable securities, choosing instruments with appropriate maturities or sufficient liquidity to provide sufficient headroom as determined by the above-mentioned forecasts.

iii.The Group has the following undrawn borrowing facilities:

Fixed rate:
Expiring within one year
Expiring over one year
June 30,2024
5,717,811
$ 100,000
5,817,811
$
December 31,2023
4,604,940
$ 100,000
4,704,940
$
June 30,2023
4,192,688
$ 100,000
4,292,688
$
  • iv.The table below analyses the Group’s non-derivative financial liabilities into relevant maturity groupings based on the remaining period at the balance sheet date to the contractual maturity date for non-derivative financial liabilities. The amounts disclosed in the table are the contractual undiscounted cash flows.
June 30, 2024
Non-derivative financial liabilities:
Short-term borrowings
Accounts payable
Other payables
Lease liabilities
Guarantee deposits received
Long-term borrowings
(including current portion)
December 31, 2023
Non-derivative financial liabilities:
Short-term borrowings
Accounts payable
Other payables
Lease liabilities
Guarantee deposits received
Long-term borrowings
(including current portion)
Lessthan 1year
1,623,105
$ 1,044,253
999,578
19,192
-
917,388
Lessthan 1year
2,242,356
$ 1,240,588
917,502
20,916
-
-
1 to 3 years
-
$ -
-
21,945
37,980
-
1 to 3 years
-
$ -
-
24,483
36,431
924,967
Over3 years
-
$ -
-
100,140
-
-
Over3 years
-
$ -
-
105,411
-
-

~51~

June 30, 2023
Non-derivative financial liabilities:
Short-term borrowings
Short-term notes and bills payable
Accounts payable
Other payables
Lease liabilities
Guarantee deposits received
Long-term borrowings
(including current portion)
Lessthan 1year
2,251,624
$ 99,934
1,470,145
1,015,253
22,820
-
-
1 to 3 years
-
$ -
-
-
29,557
35,737
933,788
Over3 years
-
$ -
-
-
107,234
-
-

(3) Fair value estimation

  • A. The different levels that the inputs to valuation techniques are used to measure fair value of financial and non-financial instruments have been defined as follows:

  • Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date. A market is regarded as active where a market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis.

  • Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

  • Level 3: Unobservable inputs for the asset or liability. The fair value of the Group’s investment in equity investment without active market.

  • B. Fair value information of investment property at cost is provided in Note 6(9).

  • C. Financial instruments were not measured at fair value, including the carrying amounts of cash and cash equivalents, financial assets at amortised cost, notes receivable, accounts receivable, other receivables, deposits paid, short-term borrowings, short-term notes and bills payable, accounts payable, other payables, long-term borrowings (including current portion), deposit received and lease liabilities are approximate to their fair values.

~52~

  • D. The related information of financial and non-financial instruments measured at fair value by level on the basis of the nature, characteristics and risks of the assets and liabilities are as follows:

  • (a) The related information of natures of the assets is as follows:

June 30, 2024
Assets
Recurring fair value
measurements
Financial assets at fair
value through profit
or loss
Unlisted stocks
Hybrid instruments
Financial assets at fair
value through other
comprehensive income
Unlisted stocks
December 31, 2023
Assets
Recurring fair value
measurements
Financial assets at fair
value through profit
or loss
Unlisted stocks
Hybrid instruments
Financial assets at fair
value through other
comprehensive income
Unlisted stocks
Level 1
-
$ -
-
-
$ Level 1
-
$ -
-
-
$
Level 2
-
$ -
-
-
$ Level 2
-
$ -
-
-
$
Level3
89,240
$ 36,163
38,361
163,764
$ Level3
89,789
$ 34,218
38,461
162,468
$
Total
89,240
$ 36,163
38,361
163,764
$
Total
89,789
$ 34,218
38,461
162,468
$

~53~

June 30, 2023
Assets
Recurring fair value
measurements
Financial assets at fair
value through profit
or loss
Unlisted stocks
Hybrid instruments
Financial assets at fair
value through other
comprehensive income
Unlisted stocks
Level 1
-
$ -
-
-
$
Level 2
-
$ -
-
-
$
Level3
76,460
$ 31,140
71,545
179,145
$
Total
76,460
$ 31,140
71,545
179,145
$
  • (b) The methods and assumptions the Group used to measure fair value are as follows:

    • i. Except for financial instruments with active markets, the fair value of other financial instruments is measured by using valuation techniques. The fair value of financial instruments measured by using valuation techniques can be referred to current fair value of instruments with similar terms and characteristics in substance, discounted cash flow method or other valuation methods, including calculated by applying model using market information available at the consolidated balance sheet date.
  • ii. The output of valuation model is an estimated value and the valuation technique may not be able to capture all relevant factors of the Group’s financial and non-financial instruments. Therefore, the estimated value derived using valuation model is adjusted accordingly with additional inputs.

  • E. For the six-month periods ended June 30, 2024 and 2023, there was no transfer between Level 1 and Level 2.

  • F. The following table is the movement of Level 3 for the six-month periods ended June 30, 2024 and 2023:

and 2023:
2024 2023
At January 1 $ 162,468
$ 158,539
Purchases in the period - 30,325
Losses recognised in profit or loss ( 549)
( 7,141)
Gains recognised in other comprehensive (loss)
income ( 4,400)
1,658
Proceeds from capital reduction in the period ( 1,607)
( 2,323)
Effect of exchange rate changes 7,852 ( 1,913)
At June 30 $ 163,764 $ 179,145
  • G. For the six-month periods ended June 30, 2024 and 2023, there was no transfer in or out from Level 3.

~54~

  • H. Accounting Department segment is in charge of valuation procedures for fair value measurements being categorised within Level 3, which is to verify independent fair value of financial instruments. Such assessment is to ensure the valuation results are reasonable by applying independent information to make results close to current market conditions, confirming the resource of information is independent, reliable and in line with other resources and represented as the exercisable price, and frequently calibrating valuation model, performing back-testing, updating inputs used to the valuation model and making any other necessary adjustments to the fair value.

  • I. The following is the qualitative information of significant unobservable inputs and sensitivity analysis of changes in significant unobservable inputs to valuation model used in Level 3 fair value measurement:

(Blank below)

~55~

Financial assets at
fair value through
profit or loss
Unlisted stocks
Hybrid instrument
-Convertible notes
Financial assets at
fair value through
other comprehensive
income
Unlisted stocks
Unlisted stocks
Fair value at
June 30,
2024
Valuation
technique
Significant
unobservable input
Relationship of
inputs to
fair value
$ 89,240
36,163
38,361
-
Market
comparable
companies
Binomial
model
Net asset value
Discounted
cash
flow
Price to
earnings ratio
multiple, price
to book ratio
multiple, discount
for lack of
marketability,
control premium
Discount rate
Not applicable
Long-term
revenue growth
rate,
weighted average
cost of
capital, long-
term pre-tax
operating
margin,
discount for
lack of
marketability,
discount for
lack of control
The higher the
multiple and
control
premium, the
higher the fair
value
The higher the
discount rate,
the lower the
fair value
Not applicable
The higher the
long-term
revenue growth
rate and the
long-term
pre-tax
operating
profit, the
higher the
fair value;
the higher
the weighted
average cost
of capital
and minority
equity discount,
the lower
the fair value

~56~

Financial assets at
fair value through
profit or loss
Unlisted stocks
Hybrid instrument
-Convertible notes
Financial assets at
fair value through
other comprehensive
income
Unlisted stocks
Unlisted stocks
Fair value at
December
31,2023
Valuation
technique
Significant
unobservableinput
Relationship of
inputs to
fairvalue
$ 89,789
34,218
38,461
-
Market
comparable
companies
Binomial
model
Net asset value
Discounted
cash
flow
Price to
earnings ratio
multiple, price
to book ratio
multiple, discount
for lack of
marketability,
control premium
Discount rate
Not applicable
Long-term
revenue growth
rate,
weighted average
cost of
capital, long-
term pre-tax
operating
margin,
discount for
lack of
marketability,
discount for
lack of control
The higher the
multiple and
control
premium, the
higher the fair
value
The higher the
discount rate,
the lower the
fair value
Not applicable
The higher the
long-term
revenue growth
rate and the
long-term
pre-tax
operating
profit, the
higher the
fair value;
the higher
the weighted
average cost
of capital
and minority
equity discount,
the lower
the fair value

~57~

Financial assets at
fair value through
profit or loss
Unlisted stocks
Hybrid instrument
-Convertible notes
Financial assets at
fair value through
other comprehensive
income
Unlisted stocks
Unlisted stocks
Fair value at
June 30,
2023
Valuation
technique
Significant
unobservableinput
Relationship of
inputs to
fairvalue
$ 76,460
31,140
34,655
36,890
Market
comparable
companies
Binomial
Mode
Net asset value
Discounted
cash
flow
Price to
earnings ratio
multiple, price
to book ratio
multiple, discount
for lack of
marketability,
control premium
Discount rate
Not applicable
Long-term
revenue growth
rate,
weighted average
cost of
capital, long-
term pre-tax
operating
margin,
discount for
lack of
marketability,
discount for
lack of control
The higher the
multiple and
control
premium, the
higher the fair
value
The higher the
discount rate,
the lower the
fair value
Not applicable
The higher the
long-term
revenue growth
rate and the
long-term
pre-tax
operating
profit, the
higher the
fair value;
the higher
the weighted
average cost
of capital
and minority
equity discount,
the lower
the fair value

~58~

13. SUPPLEMENTARY DISCLOSURES

(1) Significant transactions information

  • A. Loans to others: Please refer to table 1.

  • B. Provision of endorsements and guarantees to others: None.

  • C. Holding of marketable securities at the end of the period (not including subsidiaries, associates and joint ventures) : Please refer to table 2.

  • D. Acquisition or sale of the same security with the accumulated cost exceeding NT$300 million or 20% of the Company’s paid-in capital: None.

  • E. Acquisition of real estate reaching NT$300 million or 20% of paid-in capital or more: None.

  • F. Disposal of real estate reaching NT$300 million or 20% of paid-in capital or more: None.

  • G. Purchases or sales of goods from or to related parties reaching NT$100 million or 20% of paidin capital or more: Please refer to table 3.

  • H. Receivables from related parties reaching NT$100 million or 20% of paid-in capital or more: Please refer to table 4.

  • I. Trading in derivative financial instruments undertaken during the reporting periods: None.

  • J. Significant inter-company transactions during the reporting period: Please refer to table 5.

(2) Information on investees

Names, locations and other information of investee companies (not including investees in Mainland China): Please refer to table 6.

(3) Information on investments in Mainland China

  • A. The related information of investments in Mainland China: Please refer to table 7.

  • B. Significant transactions, either directly or indirectly through a third area, with investee companies in Mainland China: Please refer to table 3 ~ table 5.

(4) Major shareholders information

Please refer to table 8.

14. SEGMENT INFORMATION

(1) General information

The Group mainly operates in one segment. The Chief Operating Decision-Maker reviews the Group’s reporting to assess performance and allocate resources. The Group mainly has one single reportable segment.

(2) Measurement of segment information

The Group evaluates performance based on profit or loss by using sales revenue and operation profit measurements. The accounting policies of the Group's operating segments are the same as the significant accounting policies summarised in Note 4.

~59~

(3) Information about segment profit or loss, assets and liabilities

The Group has a single reportable segment. The revenue from external customers, the related gain or loss, and the assets correspond with the consolidated revenue, consolidated operating income, and consolidated assets.

(4) Reconciliation for segment income (loss)

The amounts provided to the Chief Operating Decision-Maker with respect to department assets, liabilities and profit are measured in a manner consistent with that of the financial statements.

(Blank below)

~60~

Table 1

Altek Corporation and subsidiaries Loans to other For the six-month period ended June 30, 2024

Expressed in thousands of NTD (Except as otherwise indicated)

No. Creditor Borrower General
ledger
account
Is a
related
party
Maximum
outstanding
balance during
the six-month
period ended June 30,
2024
Balance at
June 30,
2024
Actual amount
drawn down
Interest
rate
Nature of
loan
Amount of
transactions
with the
borrower
Reason
term
financing
Allowance
for
doubtful
accounts
Collateral Collateral Limit on loans
granted to
a single party
(Note)
Ceiling on
total loans
granted
(Note)
Item Value
0
1
2
Altek Corporation
Altek (Kunshan) Co., Ltd.
Altek International Holding
(BVI) Co., Ltd.
Altek
Semiconductor
Corporation
Altek Optical
Technology
(Kunshan) Co. ,
Ltd.
Altek Medical Pte.
Ltd.
Other
receivables-
related party
Other
receivables-
related party
Other
receivables-
related party
Yes
Yes
Yes
250,000
$ 45,797
227,815
250,000
$ 45,532
227,150
-
$ 45,532
64,900
2%
3%
0%
Reason
for
short-term
financing
Reason
for
short-term
financing
Reason
for
short-term
financing
-
$ -
-
Operational
need
Operational
need
Operational
need
-
$ -
-
N/A
N/A
N/A
-
$ -
-
911,933
$ 774,814
406,071
3,647,733
$ 1,549,628
1,353,568

Note 1: If the amount of NTD in this Note relates to foreign currencies, it is converted to NTD at the exchange rate at the end of the financial reporting period.

Note 2: The ”Procedure for Provision of Loans” policy for loans granted by Altek Corporation is as follows: the ceiling on total loans is 40% of the net assets value of lender. For a single enterprise, the ceiling on loans is 10% of the net assets value of lender.

Note 3: The ”Procedure for Provision of Loans” policy for loans granted by Altek (Kunshan) Co., Ltd. is as follows: the ceiling on total loans is 40% of the net assets value of lender. For a single enterprise, the ceiling on loans is 20% of the net assets value of lender.

Note 4: The ”Procedure for Provision of Loans” policy for loans granted by Altek International Holding (BVI) Co., Ltd. is as follows: the ceiling on total loans is 100% of the net assets value of lender. For a single enterprise, the ceiling on loans is 30% of the net assets value of lender.

Table 1

Altek Corporation and subsidiaries

Holding of marketable securities at the end of the period (not including subsidiaries, associates and joint ventures)

June 30, 2024

June 30, 2024
Table 2
Securitiesheld by
Marketable securities Relationship with the
securitiesissuer
General
ledgeraccount
As ofJune 30,2024
Expressed in thousands of NTD
(Except as otherwise indicated)
Numberofshares Bookvalue Ownership (%) Fairvalue
Altek Corporation
Altek Medical Pte. Ltd.
Altek Corporation
Altek (Kunshan) Co., Ltd.
Altek EMS (Kunshan) Co.,
Ltd.
Altek International
Investment Co., Ltd.
"
"
Gianta Co., Ltd. - Common stock
Profusa, Inc.-Convertible notes
Hua-chuang Automobile Information
Technical Center Co., Ltd. - Common
stock
CPEC Huachuang Private Equity
(Kunshan) Enterprise (Limited
Partnership)
Aimore Acoustics Incorporation
Apple Inc.-Corporate bond
Microsoft Corp-Corporate bond
Procter & Gamble Company-Corporate
bond
Director
None
None
None
Director
None
None
None
Financial assets at fair value
through profit or loss
- non-current
"
Financial assets measured at
fair value through other
comprehensive income
- non-current
"
"
Financial assets at amortised
cost - non-current
"
"
762,876
-
2
N/A
N/A
N/A
N/A
N/A
89,240
$ 36,163
-
38,361
-
95,271
94,893
93,349
14.55%
N/A
0.00%
1%
12.5%
N/A
N/A
N/A
89,240
$ 36,163
-
38,361
-
95,271
94,893
93,349

Table 2

Table 3

Altek Corporation and subsidiaries

Purchases or sales of goods from or to related parties reaching NT$100 million or 20% of paid-in capital or more

For the six-month period ended June 30, 2024

Expressed in thousands of NTD (Except as otherwise indicated)

Purchaser/seller Counterparty Relationship with the
counterparty
Transaction Transaction Differences in transaction terms
compared to third party
transactions
Differences in transaction terms
compared to third party
transactions
Notes/accounts
receivable(payable)
Notes/accounts
receivable(payable)
Purchases
(sales)
Amount Percentage of
total purchases
(sales)
Credit term Unitprice Credit term Balance Percentage of
total notes/accounts
receivable(payable)
Altek Corporation
Altek International
Trading Co., Ltd.
Altek Biotechnology
Corporation
Altek Medical Pte. Ltd.
"
Altek (Kunshan) Co., Ltd.
Altek International
Trading Co., Ltd.
Altek (Kunshan) Co., Ltd.
Altek Medical (Kunshan)
Limited
Altek Medical (Kunshan)
Limited
Altek Biotechnology
Corporation
Altek International
Trading Co., Ltd.
Parent-subsidiary
The same ultimate
parent company
The same parent
company
Parent-subsidiary
Parent-subsidiary
The same parent
company
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
857,346
$ 967,771
845,477
232,871
757,512
124,657
88%
100%
100%
23%
74%
9%
Net 120 days
Net 75 days
"
"
"
"
Approximately
the same price
with third
parties
"
"
"
"
"
Note
"
"
"
"
"
563,187)
($ 323,420)
(
371,003)
(
169,984)
(
513,265)
(
-
86%
100%
99%
24%
71%
0%

Note: The payment term with third parties was net 60~120 days.

Table 3

Altek Corporation and subsidiaries

Receivables from related parties reaching NT$100 million or 20% of paid-in capital or more

June 30, 2024

Table 4

Expressed in thousands of NTD (Except as otherwise indicated)

Creditor Counterparty Relationship
with the counterparty
Balance as atJune30,2024 Turnover rate Overdue receivables Overdue receivables Amount collected
subsequent to the
balance sheet date
Allowance for
doubtful accounts
Note
Amount Action taken
Altek International
Trading Co., Ltd.
Altek (Kunshan) Co., Ltd.
Altek Medical (Kunshan) Limited
"
Altek Biotechnology
Corporation
Altek Corporation
Altek International
Trading Co., Ltd.
Altek Biotechnology
Corporation
Altek Medical Pte. Ltd.
"
Parent-subsidiary
The same ultimate
parent company
The same parent
company
Parent-subsidiary
Parent-subsidiary
563,187
$ 323,420
371,003
169,984
513,265
3.41
5.02
4.16
6.16
5.42
-
$ -
-
-
-
N/A
N/A
N/A
N/A
N/A
89,714
$ 81,156
246,714
51,277
296,986
-
$ -
-
-
-

Note: It is a loan to related party, shown as other receivables.

Table 4

Altek Corporation and subsidiaries

Significant inter-company transactions during the reporting periods

For the six-month period ended June 30, 2024

Table 5

Expressed in thousands of NTD

(Except as otherwise indicated)

Companyname Counterparty Relationship
(Note1)
Transaction
General ledgeraccount Amount Transactionterms Percentage of consolidated total operating
revenues ortotalassets (Note2)
Altek Corporation
"
Altek International Trading Co., Ltd.
"
Altek Biotechnology Corporation
"
Altek Medical Pte. Ltd.
"
"
"
"
"
Altek Medical Sdn.Bhd.
"
Altek (Kunshan) Co., Ltd.
Altek Medical (Kunshan) Limited
"
Altek International Trading Co., Ltd.
"
Altek (Kunshan) Co., Ltd.
"
Altek Medical (Kunshan) Limited
"
Altek Medical (Kunshan) Limited
"
Altek Biotechnology Corporation
"
Altek Medical Sdn.Bhd.
"
Altek Medical (Kunshan) Limited
"
Altek International Trading Co., Ltd.
Altek (Kunshan) Co., Ltd.
"
(1)
(1)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
Purchases
Accounts payable
Purchases
Accounts payable
Purchases
Accounts payable
Purchases
Accounts payable
Purchases
Accounts payable
Purchases
Accounts payable
Purchases
Accounts payable
Purchases
Purchases
Accounts payable
857,346
$ 563,187
967,771
323,420
845,477
371,003
232,871
169,984
757,512
513,265
39,110
38,612
50,223
49,983
124,657
36,065
94,672
Net 120 days
"
Net 75 days
"
"
"
"
"
"
"
"
"
"
"
"
"
"
26%
4%
29%
2%
26%
2%
7%
1%
23%
3%
1%
0%
2%
0%
4%
1%
1%

Note 1: Relationship between transaction and counterparty is classified into the following categories:

(1) Parent company to subsidiary.

(2) Subsidiary to parent company.

(3) Subsidiary to subsidiary.

Note 2: Regarding percentage of transaction amount to consolidated total operating revenues or total assets, it is computed based on period-end balance of transaction to consolidated total assets for balance sheet accounts and based on accumulated transaction amount for the period to consolidated total operating revenues for income statement accounts.

Note 3: The Company may decide to disclose or not to disclose transaction details in this table based on the Materiality Principle.

Table 5

Altek Corporation and subsidiaries

Information on investees

Expressed in thousands of NTD (Except as otherwise indicated)

For the six-month period ended June 30, 2024

Table 6

Investor Investee Location Main business activities Initial investment amount Initial investment amount Shares held as at June 30, 2024 Net profit (loss) of
the investee
for the six-month period
ended June 30,2024
Investment income(loss)
recognised by the Company
for the the six-month period
ended June 30,2024
Footnote
Balance
as at June 30,
2024
Balance
as at December 31,
2023
Number of shares Ownership (%) Book value
Altek Corporation
"
"
"
"
Altek International
Investment Co., Ltd.
"
"
"
Altek Semiconductor
(Cayman) Co., Ltd.
Altek Medical Pte. Ltd.
"
"
"
Altek International
Investment Co., Ltd.
Altek Japan Corporation
Altek International Holding
(BVI) Co, Ltd.
Altek Investment Corporation
Altek Medical Pte. Ltd.
Altek Lab Inc.
Altek Semiconductor
(Cayman) Co., Ltd.
Altek Optical Technology
(Cayman) Co., Ltd.
Altek International
Trading Co,. Ltd.
Altek Semiconductor
Corporation
Altek Biotechnology
Corporation
Altek Medical (HongKong)
Limited
Altek Biotechnology Pte.
Ltd.
Altek Medical Sdn.Bhd.
British Virgin
Islands
Japan
British Virgin
Islands
Republic of China
Singapore
U.S.A.
Cayman Islands
Cayman Islands
Republic of
Seychelles
Republic of China
Republic of China
HongKong
Singapore
Malaysia
Investment
Buying and selling of electronic
components
Investment
Investment
Research and development, sales of
medical electronic equipment and
investment
Collection of American digital imaging
technology information and design
services
Investment
Investment
Intercompany transactions
Research design and sales of ASIC
Research and development,
manufacture and sales of
medical electronic equipments
Investment
Research and development,
and sales of medical electronic
equipments
Manufacture and sales of medical
electronic equipments
$ 2,882,512
2,869
415,376
100,000
755,272
119,407
433,117
429,833
324,500
500,000
25,376
48,675
16,225
129,800
2,882,512
$ 2,869
415,376
100,000
755,272
119,407
433,117
429,833
324,500
500,000
25,376
38,940
16,225
64,900
87,769,559
1,000
12,865,921
10,000,000
45,063,684
11,311,875
43,000,000
13,246,000
10,000,000
50,000,000
1,100,000
N/A
500,000
18,234,000
100
100
100
100
69.87
100
100
100
100
100
100
100
100
100
8,595,028
$ 9,396
1,382,668
100,361
848,408
69,937
123,442
144,506
237,056
118,328
963,457
102,912
13,068
111,488
96,977
$ 53
27,717
126
212,031
760
14,629
1,737
14,996)
(
14,576
105,598
9,136)
(
25
7,637)
(
98,771
$ 53
27,717
126
156,260
760
15,993
1,737
14,996)
(
14,576
78,384
6,890)
(
17
5,053)
(
Note 1
Note 1
Note 2
Note 1
Note 2
Note 2
Note 2
Note 2
Note 1
Note 2

Note 1: The difference between the profit or loss of the investee for the current period and the investment profit or loss recognized in the current period is the unrealized profit and loss adjustments for countercurrent transactions between subsidiaries. Note 2: The difference between the profit and loss of the investee company in the current period and the investment profit and loss recognized in the current period is based on the shareholding ratio.

Table 6

Altek Corporation and subsidiaries

Information on investments in Mainland China

Table 7

Expressed in thousands of NTD

For the six-month period ended June 30, 2024

(Except as otherwise indicated)

Investee in Mainland
China
Main business activities Paid-in capital Investment
method
Note 1
Accumulated amount
of remittance from
Taiwan to Mainland
China as of
January1,2024
Amount remitted from Taiwan to
Mainland China/Amount
remitted back to Taiwan for
the six-month period ended
June 30,2024
Amount remitted from Taiwan to
Mainland China/Amount
remitted back to Taiwan for
the six-month period ended
June 30,2024
Accumulated amount
of remittance from
Taiwan toMainland
China as of
June 30,2024
Net profit (loss) of investee
for the six-month
period ended
June 30,2024
Ownership held by
the Company
(direct or indirect)
Investment income
(loss) recognised
by the Company
for the six-month
period ended
June 30, 2024
(Note 4)
Accumulated amount
of investment income
remitted back to
Taiwan as of
June 30,2024
Book value of
investments in
Mainland China as of
June 30,2024
Remitted to
MainlandChina
Remitted back to
Taiwan
Altek (Kunshan) Co.,
Ltd. (Note 2)
Manufacture and sale of digital
still cameras and its accessories
572,094
$ 2
1,460,250
$ -
$ Altek EMS (Kunshan)
Co., Ltd. (Note 3)
Production /sales of electronic
product components
162,250
2
294,743
-
Altek Trading
(Shanghai) Limited
Wholesale, import and export of
digital cameras, digital video
cameras and their
associated accessories
275,825
2
275,825
-
Altek Precision
(Kunshan) Co., Ltd.
Design, manufacture and sales of
digital camera parts
447,810
2
447,810
-
Altek Optical
Technology
(Kunshan)
Co., Ltd.
Manufacture and sale of
components for electronic
related products
454,300
2
431,585
-
Altek Semiconductor
(Shanghai) Co., Ltd.
Research design and sales of
imaging technologies,
electronic software and
hardware
48,675
2
-
-
Altek Medical
(Shanghai) Limited
Sales of medical electronic
equipment
32,450
2
-
-
Altek Medical
(Kunshan) Limited
Manufacture and sale of medical
electronic equipment
27,319
2
-
-
Jia Jing Business
Management (Kunshan)
Co., Ltd. (Note 5)
Business management and
non-residential real estate leasing
613,954
2
-
-
Hong Jing Business
Management (Kunshan)
Co., Ltd. (Note 5)
Business management, housing
leasing and property management
423,473
2
-
-
Note 1: Investment methods are classified into the following three categories; fill in the number of category each case belongs to:
(1)Directly invest in a company in Mainland China.
(2)Through investing in an existing company in the third area,which then investeed in the investee in Mainland China.
(3)Others.
Note 2: Including retained earnings capitalized of US$4,600 (In thousand of US dollars).
Note 3: Including retained earnings capitalized of US$3,600 (In thousand of US dollars).
Note 4: The basic explanation of investment profit and loss recognition is audited by the R.O.C. parent company’s independent auditors.
(1)Altek (Kunshan) Co., Ltd. are reviewed by the R.O.C. parent company’s independent auditors.
(2)Other companies are self-consolidated financial statements.
Note 5: It was established by Altek (Kunshan) Co., Ltd.
Companyname
Accumulated amount of remittance from Taiwan to
Mainland China as of June 30,2024
-
$ 1,460,250
$ 91,151
$ -
294,743
5,076
-
275,825
9,163)
(
-
447,810
1,718
-
431,585
2,316
-
-
2,815)
(
-
-
3,080)
(
-
-
11,811
-
-
20,485
-
-
6,794)
(
Investment amount approved by the Investment
Commission of the Ministryof Economic Affairs(MOEA)
100
91,151
$ 3,874,100
$ -
$ 100
5,076
580,202
97,350
100
9,163)
(
276,742
-
100
1,718
168,796
-
75
1,737
144,503
-
100
2,815)
(
106,729
-
69.87
2,407)
(
92,818
-
69.87
8,630
85,292
-
100
20,485
681,003
-
100
6,794)
(
448,430
-
Ceiling on investments in Mainland China imposed
bythe Investment Commission of MOEA
Altek Corporation $2,910,213 $3,192,225 $5,471,599

Accumulated amount of remittance from Taiwan to Company name Mainland China as of June 30, 2024 Altek Corporation $2,910,213

Table 7

Altek Corporation and subsidiaries Information of major shareholders June 30, 2024

Table 8

Name of major shareholders Shares Shares
Number of shares held Holding percentage
Yitsang International Co., Ltd. 14,830,100 5.31%

Table 8